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Abstract 
DAVID PFAEHLER: Electronic Health Records and Health Information Exchange and 
Their Impact on International Healthcare System Efficiency 
(Under the direction of Dr. Katherine Centellas) 
 
The 19th century epidemiological transition in healthcare caused a major shift in 
physician focus from curing one-time, deadly illness to managing chronic disease. Now, 
even the most advanced international healthcare systems must find a way to increase their 
efficiency in order to compensate for heightened strains on medical systems and swelling 
costs of healthcare delivery. Fortunately, recent technological innovation and, chiefly, the 
growth of Electronic Health Records (EHRs) provide a potential solution to this looming 
threat. EHRs are digital charts with the potential to store and share patient health data 
among providers to offer the most informed, streamlined care available. Yet, their 
effectiveness in increasing health system efficiency remains uncertain. Relying on the 
concept of technical efficiency in the healthcare sector, I explore the efficacy of long-
term international EHR implementation. Using OECD data, I performed a Stochastic 
Frontier Analysis (SFA) and measured the change in hospital subsector efficiency over 
time for each of the 15 chosen countries within my analysis. Followed by this data is a 
comprehensive EHR index as well as 5 individual country case studies to better explain 
the histories, successes, and failures of EHR implementation throughout the world. These 
measures yielded somewhat inconclusive results pertaining to EHR’s effect on 
international healthcare efficiency. Nevertheless, the findings of this study strongly 
support the need for continued international healthcare efficiency analysis. Rather than 
submit to the difficulties of such nuanced and complex analytical processes, researchers 
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must remain vigilant and steadfast in their pursuit of efficiency in order to provide 
effective, affordable healthcare to everyone in need.  
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Chapter One: Introduction 
Imagine a world void of waste and procrastination--a world where every resource 
was wisely used and seldom wasted. Sure, this idea of maximum efficiency might seem 
like a utopian concept, but what if it were realistically achievable? To be efficient is 
generally described as the ability to “be capable of producing desired results with little or 
no waste (as of time or materials),” (Merriam-Webster, 2020). Efficiency in any walk of 
life allows one to do more with less, thus increasing effectiveness, productivity, and 
profit. Nations around the globe have been consumed by the idea of increased efficiency 
in their governmental systems for quite some time. Over the last several decades, 
transportation systems have evolved to move more people over longer distances in 
shorter amounts of time and food systems grow produce and livestock bigger and faster 
than ever before. Thanks to these developments, invaluable resources--most notably time 
and money--have been conserved and society is considerably more productive than it was 
just decades ago. These accomplishments in the food and transportation system are 
undeniable, but how have more nuanced entities like healthcare systems been modified 
and made more efficient over this same period of time?  
Many nations have made remarkable improvements to their healthcare systems of 
old, attaining higher standards of quality care and spending less money along the way. 
These improvements are absolutely necessary as the world’s population continues to 
grow older, more overweight and obese, and significantly more likely to be diagnosed 
with chronic conditions and diseases that require frequent visits to healthcare facilities. 
One might ask how these countries have managed to accomplish this challenging task of 
reforming their outdated healthcare systems, but the answer that continues to reappear in 
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each of these situations is not quite as complex as one might think: technological 
innovation.  
There have been numerous recent technological innovations that have improved 
the efficiency of healthcare systems. These innovations use groundbreaking software to 
make the most of the resources they have available--whether human or financial. 
Suddenly, a medical discovery that once required millions of dollars in funding now only 
requires a fraction of the cost. Better yet, a physician that could only care for several 
hundred patients a week can now effectively treat thousands. Artificial intelligence, 
virtual reality simulations, and three-dimensional printers are just a handful of a 
seemingly endless number of cutting-edge innovations that have helped healthcare 
professionals improve their quality of care--but have electronic health records (EHRs) 
and health information exchange (HIE) had a similar impact on healthcare professionals 
and the systems in which they work? 
Electronic health records are defined as “a longitudinal electronic record of 
patient health information generated by one or more encounters in any care delivery 
setting. Included in this information are patient demographics, progress notes, problems, 
medications, vital signs, past medical history, immunizations, laboratory data, and 
radiology reports,” (Menachemi, 2011, p. 48). Some of the basic benefits associated with 
the use of EHRs include easy access of computerized records and the elimination of poor 
penmanship. Additionally, three functionalities of EHRs that hold great promise in 
improving quality of care and reducing cost are clinical decision support (CDS) tools, 
computerized physician order entry (CPOE) systems, and health information exchange 
(HIE) capabilities (Menachemi, 2011). These dynamic functions certainly paint digital 
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patient charts in an attractive light, but EHRs have also faced their fair share of criticism 
from those skeptical about their practicality in modern healthcare settings. While health 
information technology can operate in useful ways and promote more efficient systems, it 
can also be expensive, difficult to implement effectively, and even lead to burnout among 
healthcare workers (Brown, 2019). As the need for more intelligent and flexible 
healthcare systems continues to grow, it is imperative to determine whether EHR and 
HIE truly help enhance efficiency within medical care settings.  
This task of defining efficiency can be a difficult undertaking for any sector of the 
economy. Even more so, defining efficiency in the health sector and within the context of 
EHR and HIE conjures an entirely new layer of nuance and subjectivity. Each and every 
health system--regardless of the country--varies greatly and is uniquely challenging to 
measure. The majority of efficiency studies of healthcare systems rarely conform to 
production-line overviews in which a set of clearly identifiable inputs is used to produce 
a standard type of output. Instead, health care is designed to meet the specific needs of an 
individual patient, with various circumstances, preferences, and needs--ultimately leading 
to considerable variation in how inputs are consumed and outputs are produced. The 
unfortunate reality is that health systems are extremely complex and there is often no 
consensus on which countries perform most efficiently, which method is the most 
appropriate, or which health outcomes should be directly attributed to certain healthcare 
inputs. Therefore, it is easy to understand that measuring efficiency within healthcare 
systems comes with serious obstacles in comprehending how systems function, evolve, 
and ultimately rank.  
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Yet, in an era characterized by cloud computing breakthroughs and pressures to 
digitize patient data for increased coordination, it makes sense now more than ever that 
electronic versions of a patient’s paper chart could be a tool that many healthcare systems 
should be able and willing to implement in order to improve their system efficiency--
especially as global health trends shift unfavorably towards populations that are 
increasingly old, obese, and chronically ill. This reality alone illustrates an immense need 
for effective, interoperable, streamlined care that can increase efficiency by limiting the 
amount of inputs a system must consume in order to arrive at a certain output level. In 
fact, many countries have already taken the leap on this front and, although the 
implementation of a health information exchange network is relatively new, this 
technology has emerged as a promising agent for improving the quality and reducing the 
cost of healthcare systems for many inquisitive nations aspiring for increased efficiency.  
In the following chapters, the idea of utilizing EHR and HIE systems to increase 
health system efficiency is explored in more detail. We first begin by illustrating the 
modern need for more efficient healthcare delivery and the efficacy of EHR 
implementation. Next, we shift to the importance, methodology, and challenges of 
analyses involving international healthcare system efficiency. Afterwards, a 
comprehensive data analysis is utilized to provide an efficiency score for each of the 
fifteen countries within question. These scores are then compared over various time 
periods depending on each nation’s EHR implementation date. Finally, case studies for 
five separate countries are provided to shed further light onto the real-life successes, 
failures, and intricacies of EHR and HIE implementation. All of this is done with the 
hope of gaining a more precise understanding of not only whether EHRs have affected 
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international health system efficiency, but also at what point, to what degree, and in what 
aspects.  
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Chapter Two: History and Background 
Epidemiological Shift: Illnesses Turn Chronic 
Before exploring the efficacy of new technological tools in healthcare such as the 
electronic health record and health information exchange, it is first important to explain 
the sequence of events that have brought about the need for such innovations. Similar to 
any other branch of science, medicine has changed considerably over the last several 
centuries--and almost exclusively for the better. However, with these advances also came 
an equal share of unforeseen challenges.  
Premodern medicine began in the western world of ancient Greece as a once 
fundamentally intuitive branch of knowledge. Good physicians were thought to enter the 
world as natural-born caretakers--literally being predestined to enter the healing arts in a 
way of thinking that more closely resembled religion than science. However, in the early 
1500s premodern medical practice gradually dissolved and physicians began to 
modernize their caretaking process into a practice more consistent with what we see 
today. Human beings increasingly saw themselves as distinct and exceptional within the 
natural order of things and began their pursuit of conquering nature and the challenges it 
posed.  
This growth of science and technology fueled the idea that human ingenuity could 
and should harness and control the risks of the natural environment. Enlightenment 
metaphysicians like René Descartes expanded upon these ideas by developing new 
theories based on mechanistic physiological philosophies--the idea that animal (and thus, 
human) bodies are machines, constituted by material mechanisms, and governed by the 
laws of matter alone (Stanford, 2014). Robert Boyle, largely regarded as the first modern 
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chemist, furthered this neoteric belief through his work by treating patients with various 
drugs which targeted particular illnesses and conditions. Boyle even attested that he was 
more knowledgeable and effective in treating patients than were the era’s physicians 
(Shapin, 2000). This newly established idea of nature as a studiable and controllable 
entity gave rise to medical thinking in the West that became increasingly dominated by a 
human responsibility to cure, manage risk and predictability, and focus on material 
objects and empirical processes.  
Healthcare, like premodern physician practice, experienced a similar evolution 
from a process of caring at homes; avoiding physiological examination; and thinking 
deeply and intuitively about realigning divining imbalances to a modern process of caring 
for patients in hospitals or office buildings; analytically calculating cases; and 
quarantining patients in order to maximize efficiency in a factory-like production. Just as 
the world economy began to flourish and crystallize--stressing the need for standardized 
processes to ensure consistency among the workforce--so, too, did global healthcare 
practices require an increasingly reliable and adaptable systemization of healthcare 
delivery. 
As this modernization took shape and physicians found creative ways to cure one-
time, life-threatening illnesses, patients also found themselves increasingly inflected with 
more nuanced, difficult-to-manage diseases. In the 19th century, the major causes of 
mortality were typically infectious diseases like pneumonia, tuberculosis, and 
gastrointestinal infections (Tippett, 2014). Thankfully, these conditions are largely 
eradicated today thanks to the development of antibiotics, vaccinations, sewage 
management systems, and improved education regarding sanitation and food handling. 
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Among the most important of these discoveries are the Germ Theory of Disease proposed 
by Louis Pasteur in the late 1800s and the Broad Street Pump Experiment conducted by 
John Snow in 1854. These revelations proved that pathogens and outbreaks could be 
studied, treated, and cured. And--while exceptionally beneficial for society as a whole--
the adverse effect of these breakthroughs is that a large part of modern clinical practice 
concerns the long-term management of disease, with no focus on cure. This evolution 
from one-time illnesses to chronic diseases is known today by public health experts as the 
epidemiological shift. 
Trends tend to show that as life expectancy reaches an unprecedented high of 70+ 
years, heart disease, cancer, and stroke replace infection as prime killers (Hinote, 2017). 
Even more worrisome is the fact that this burden of chronic disease is increasing 
worldwide. In high-income countries, chronic diseases have long been the leading causes 
of death and disability; and more than 70% of deaths globally are due to chronic diseases. 
In the United States, that statistic increases to more than 87% (Barrett, 2016)--although it 
should be stated that the global pandemic induced by the recent outbreak of the novel 
coronavirus COVID-19 may cause 2020 to deviate from this long-standing trend. 
Nevertheless, chronic diseases consistently and directly affect overall health care budgets, 
employee productivity, and economies. These diseases account for two-thirds of the 
overall disease burden in middle-income countries and are expected to rise to three-
quarters by 2030--often in parallel with economic development, ironically (Barrett, 
2016). Even deaths from smoking are expected to increase dramatically in low-income 
countries over this same period. In the 20th century, tobacco-use killed around 100 
million people worldwide. In the 21st century, an estimated one billion will die 
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prematurely--a tenfold increase. By 2030, more than 80% of deaths attributable to 
tobacco will be in low-income countries (CDC, 2012).  
Our world’s healthcare systems have neglected the threat of chronic disease for 
far too long. We are now entering an era that will pose countless strains on healthcare 
budgets and public health. As more and more patients find themselves diagnosed with 
chronic diseases like cancer, diabetes, and heart disease, it becomes clear that the 
epidemiological transition from one-time illnesses to chronic diseases has produced a 
world population that is less healthy and more at risk today than it was just decades ago. 
This infamous transition has been exceptionally costly--not only from the perspective of 
dollars, but, more importantly, lives--and our health systems must continue to adapt and 
evolve if we wish to continue to treat patients effectively in the future. EHR and HIE, an 
innovative healthcare tool that has shown promising signs of increasing the efficiency of 
healthcare delivery, is a potential solution to this daunting problem. 
Rising Healthcare Costs 
  Finding a way to improve care for populations that grow increasingly chronically 
ill and in need of frequent medical attention is a daunting task, but the difficulty of 
finding ways to pay for this new standard of care is equally as concerning. In the past, 
patients were frequently diagnosed with diseases that could be cured with relatively little 
care and cost. A physician could enter the room and, within minutes, administer a shot or 
prescribe a medication that would relieve the patient’s malady for good (Hinote, 2017). 
However, chronic illnesses like diabetes, heart disease, and cancer require long-term care 
that is exponentially more costly and often focuses on managing illness rather than curing 
it entirely. Health experts have highlighted the increase in spending associated with this 
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epidemiological shift, especially in the United States. In 2019, researchers from Johns 
Hopkins University found that health spending in the U.S. has been growing faster than 
other OECD countries in spite of efforts to control spending in the U.S. Their study 
revealed that overall U.S. health spending increased at an average rate of 2.8 percent 
annually between 2000 and 2016, which is greater than the OECD median annual 
increase of 2.6 percent. During that time, inflation-adjusted spending per capita on 
pharmaceuticals also increased much more quickly in the U.S. with an increase rate of 
3.8 percent per year compared to just 1.1 percent for the OECD median (JHU, 2019). 
These statistics are worrisome for a United States healthcare system that maintains one of 
the most expensive and least equitable systems among high-income countries. However, 
despite the validity of these statistics, there is an overarching trend of increased 
healthcare costs globally that is not exclusive to just the United States and this alarming 
development poses numerous international problems.  
The 2018 World Health Organization (WHO)’s global health financing report 
revealed that spending on health is growing faster than the rest of the global economy, 
accounting for 10% of global gross domestic product (GDP). This trend shows a swift 
upward trajectory of global health spending, which is particularly noticeable in low- and 
middle-income countries where health spending is growing on average at 6% annually 
compared with a 4% increase for high-income countries (WHO, 2019). These economic 
trends are often obscured by countries with healthcare systems that control prices to 
lower individual patient expenditure and blunt the effects of rising healthcare costs. 
Prescription drug price negotiation in Germany is an example of this occurrence. Prices 
are established through collective negotiations between a single buyer (representing the 
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insurers) and a single seller (the drug maker). Strong public and political pressure usually 
deter gridlock and encourage the two sides to come to an agreement--but if negotiations 
halt, the drug’s price is established by an arbitration panel with representatives from each 
side and an appointed chair. 
While governmental actions like price controls may be situationally effective in 
keeping costs low for individual patients, they contribute to exacerbated problems in 
other areas of healthcare. Britain’s National Health Service (NHS) demonstrates how 
price controls can severely hinder the performance of a healthcare system by not only 
veiling the reality of increased cost of care, but also creating problems like long wait 
times and limited patient access to treatment. According to a recent report from the Royal 
College of Surgeons, nearly a quarter of a million British patients have been waiting over 
six months to receive planned medical treatment from the NHS and more than 36,000 of 
those individuals have been in treatment queues for nine months or more (Pipes, 2019). 
Even more concerning is that patients in dire need of care are given few options for 
affordable care as “the target for treating cancer patients within 62 days of urgent GP 
referral has not been met for over 5 years,” (Thorlby, 2019). Unfortunately, issues with 
price-controlled healthcare systems do not stop in Britain. Hospitals in Japan have seen 
their cost of care limited so aggressively that almost all hospitals operate in a large 
deficit. Similarly, German physicians and other health professionals have unified and 
protested for increased salaries as they feel they are not adequately compensated for their 
work due to their country’s heavily regulated healthcare industry.  
It is imperative that one understands the differences associated with the function 
of healthcare systems around the globe. The way in which each nation utilizes their 
Pfaehler 18 
healthcare system is important, but even more so in the context of rising healthcare costs 
is analyzing how a country publicizes their healthcare data. In a healthcare system like 
that of the United States, which avoids regulating prices and redistributing costs from 
patient to patient, the rise of healthcare cost over the last few decades is unmistakable. 
However, countries that blunt the effects of rising costs through negotiations and 
distribution of the burden of cost over millions of citizens make these trends less evident. 
Nevertheless, as expressed by the WHO’s 2018 report, spending on health is increasing at 
a faster rate than any country’s economy can continue to endure. This trend exacerbates 
the need for timely change in healthcare at the international level--change as widespread 
as it is effective. In the near future, we must find a way to redefine our healthcare systems 
in order to improve care for aging populations that are increasingly plagued by chronic 
illnesses. Even more importantly, we must achieve this goal through a method that 
reduces cost and ensures the long-term sustainability of affordable healthcare 
internationally. 
The Past, Present, and Future of Electronic Health Record Use  
 Documenting a patient’s medical history and capturing this information within a 
preserved record is an idea that originated long ago. In fact, translation of ancient 
Egyptian hieroglyphic inscriptions and papyri from 1,600-3,000 BC indicate the use of 
medical records thousands of years before even premodern medicine began to take shape 
(Evans, 2016). Despite this longstanding history of patient data collection, the utilization 
of medical records has drastically changed over the last century--and with this change 
have come new facilitators, barriers, and unknowns associated with EHR use. Until the 
1920s, paper medical records were sparsely used within healthcare practices. However, 
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by the 1960s and 1970s, a technological boom of computers and data processors quickly 
laid the foundation for traditionally paper charts maintained in folders to be transformed 
into hybrid patient charts using paper records and electronic records, known today as the 
Electronic Health Record. The last several decades have been revolutionary for the EHR 
and Health Information Exchange (HIE) as a whole, but there remains some uncertainty 
about their ability to increase efficiency in modern healthcare systems. 
 In 1992, the state of EHRs experienced profound changes thanks to affordable 
hardware, powerful and compact personal computers, and accelerated internet access. 
Suddenly, what was once a hybridization of paper and computerized data began to shift 
entirely electronic. As a result, academic centers began developing more functional EHR 
systems and clinical use skyrocketed. Medical professionals started to implement EHRs 
to quickly access physician notes, orders, consults, laboratory results, and more. Before 
long, Clinical Decision Support (CDS)--a technology designed to provide physicians and 
other health professionals with assistance with clinical decision-making tasks--and 
Computerized Provider Order Entry (CPOE)--the process of entering and sending 
treatment instructions via computer applications rather than paper, fax, etc.--were added 
to the list of possible EHR operations that further improved healthcare processes. These 
tools soon became two of the most important benefits associated with EHR use 
(Menachemi, 2011). 
 Since 1992, the modern era has continued to advance and expand upon the 
Electronic Health Record. After it became obvious that a standard communicative 
language between EHR systems was needed, Health Level Seven (HL7)--an international 
standard for transfer of clinical and administrative data--was developed and began to 
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facilitate the interfacing of multiple EHR systems. Strides towards interoperability--
interfacing on a larger scale and between more systems--also took shape as large private 
vendors and governments alike began to invest in improving the capabilities, functions, 
and fluidity of EHR systems. As of 2015, EHRs are now created, used, edited, and 
viewed by multiple independent entities including primary care physicians, hospitals, 
insurance companies, and patients (Evans, 2016). As one author states, “They [EHRs] 
have changed the dynamics of the patient-clinician interaction,” (Evans, 2016) through 
clinician-patient email, virtual consults, and telemedicine.  
Outside of these dynamic changes, financial savings are another positive impact 
associated with modern EHRs. Potential yearly savings from a reduction in the 
maintenance cost of paper medical records in the U.S. alone are estimated at $1.3 billion 
with cumulative savings of $19.9 billion over 15 years. Likewise, the cumulative 
potential net efficiency and safety savings from hospital systems could be nearly $371 
billion with potential cumulative savings from physician practice electronic medical 
records (EMRs)1 at nearly $142 billion. This estimation is calculated based on efficiency 
savings only; the potential net financial benefit could double if the health savings 
produced by chronic disease prevention and management were also included (Hillestad, 
2005). Ambulatory systems also stand to benefit with savings estimated at $11 billion 
over the same period (Kumar, 2010).  
 Given these positive developments, it is clear that the EHR has become more 
accomplished and versatile as technology has continued to adapt and evolve. This reality 
 
1 Unlike EHRs, which include detailed patient medical history and have the potential to share this 
information with other providers, EMRs (Electronic Medical Records) contain only a single practice’s 
digital health chart. 
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has led to a number of innovations and possibilities, but it has also brought about 
legitimate barriers and concerns. Among the top three barriers associated with EHR 
implementation are missing data/data error, no standards, and a loss of productivity 
(Kruse, 2018). One scholar details the challenges of health information technology (HIT) 
adoption, stressing that “we cannot yet design and deploy complex software systems that 
are on time, within budget, meet the specific requirements, satisfy their users, are reliable 
(bug free and available), maintainable, and safe,” (Karsh, 2010, pg. 617). Furthermore, 
even with recent strides towards interoperability, nations have been reluctant to assume 
wide scale adoption of the technology, a step that is absolutely necessary in order to 
utilize all available benefits of an interconnected and efficient EHR system.  
More concerning for the outlook of wide scale EHR implementation is one 
author’s recent observational study which refutes the common belief that EHR 
implementation is associated with gains in measures of inpatient mortality, readmissions, 
and patient safety indicators (PSIs) (Yanamadala, 2016). In fact, data from this study of 
patients receiving medical and surgical care at various EHR and non-EHR system 
hospitals suggests that EHR implementation may actually increase the amount of time 
spent necessary to care for patients during clinic visits, thus contributing to clinic 
inefficiency. While more time with each patient may be desirable to some, this extra time 
was more frequently spent inputting redundant information than it was spent actually 
caring for the patient. Yanamadala’s article is certainly concerning for proponents of 
EHRs who believe federal incentives are necessary to further propagate the benefits 
experienced by wide scale EHR implementation. Instead of justifying calls for increased 
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federal funding, this article insists that the associated barriers may be more challenging to 
overcome than initially thought. 
 Even with incredible technological advancements, perhaps the most daunting 
challenges facing the future of EHR implementation is its potential to become too 
knowledgeable to the point of invading personal privacy. After all, newfound technology 
provides EHR systems with the potential to utilize digital pathology and other 
sophisticated tools to manage and integrate data, laboratory results, voice recognition, 
barcodes, and documentation templates. Similarly, increased hardware capacity allows 
for entire family health histories to be entered into the EHR. Used in conjunction with 
big-time data and text mining, health professionals have found ways to analyze outcomes, 
patterns, temporal trends, and correlations within families to improve both private and 
public health outcomes. Even the human genome has since been decoded, sequenced, and 
stored within modern EHR systems (Evans, 2016). These advancements are some of the 
loftiest goals for techno-optimists, but they also seriously increase anxieties about the 
security and protection of medical histories and physician-patient confidentiality. 
Nonetheless, proponents of HIE continue to develop more fluid and capable EHR 
systems and there exists a number of ingenious yet attainable expectations for EHR 
technology over the next quarter century. 
The ability of applications like the electronic health record to communicate, 
interpret, and act intelligently upon complex healthcare information is just one of a 
number of aggressive expectations for the progression of EHR systems in the future. Yet, 
while EHR and HIE has evolved considerably over the last several decades, it is more 
important for current EHRs to continue to meet the needs of modern medicine’s 
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distributed systems and rapidly changing healthcare environment rather than attempt to 
reinvent the wheel. The fundamental role and purpose of electronic health records in the 
future will be:  
“...a data repository based on international standard APIs [Application 
Programming Interfaces] for the retrieval and storage of data. It will be coupled 
with facility and vendor provided, and user selected applications for data review 
and entry and especially CDS. In addition to health data, social, economic, 
behavioral, and environmental data will play a vital role in providing and 
especially improving healthcare. The applications will be interchangeable, not 
dependent on EHR versions and updates, and will facilitate innovation like the 
current Smart Phone applications,” (Evans, 2016, p. S56). 
 
If EHRs prove capable of effectively managing these increased functions, HIE as a whole 
should expect to bolster a number of design improvements and enhanced capabilities in 
the future. Among these changes could be EHRs with: improved interoperability, 
increased use of cloud technology, longitudinal (birth to death) focuses, big data storage, 
internationally accepted standards, foreign language translations with preserved clinical 
meanings, and flexible systems (Evans, 2016). Each of these functions, both the mundane 
and the ambitious, should be shaped by experienced clinicians with a vested interest in 
the functionality and efficiency of the future EHRs.  
Of course, current and future EHRs will continue to have the potential to increase 
medical errors if used improperly; therefore, as these systems continue to change over 
time and improve, engineering and reengineering will be needed in order to increase their 
potential benefit while at the same time improving their safety. EHR safety concerns 
involving unsafe technology and unsafe use will persist in the future, but the focus of this 
issue remains on finding solutions to prospective errors rather than systemwide 
punishment of electronic health records and health information exchange. Modern data 
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and scholarly sentiment support the continued adoption of EHR and HIE within various 
healthcare systems; although, a continuation of current research on the impact of EHR 
and HIE will continue to prove beneficial in determining whether wide scale 
implementation should be incentivized or scrapped.  
Pfaehler 25 
Chapter Three: Identifying Efficiency within Healthcare Systems 
Why is Healthcare Efficiency Important? 
The study of health sector efficiency and related issues such as cost, effectiveness, 
and value for money are some of the most important dimensions of healthcare 
performance. These statistics portray the extent to which inputs to the health system are 
used to secure valued health system goals. In almost every other area of the economy, 
consumer preferences ensure that the most valued outputs are produced at market prices. 
However, all too often, this same balance is not upheld in the health sector which causes 
market failures and leads to dysfunction, poor quality, and inappropriate care. Health care 
financiers including governments, insurers, and households are interested in knowing 
which systems, providers, and treatments contribute the largest health gains in relation to 
the level of resources they consume. Especially concerning is the long-term financial 
sustainability of a number of different health resources and social safety net systems. In 
order to change the unfortunate reality of healthcare system dysfunction, the study and 
pursuit of efficiency should be the central objective of all parties invested in a high-
functioning, healthy society and state. To achieve this goal, the study of healthcare 
efficiency is essential and, to that end, better instruments for measuring and 
understanding efficiency are absolute necessities (Cylus, 2016). 
Understanding Efficiency and Inefficiency 
 Inextricably tied to healthcare efficiency--and efficiency in general--is the idea of 
inefficiency. As easily as resources can be utilized wisely, they can likewise be wasted 
foolishly. Tackling unwise resource allocation has an important accountability value as it 
is essential to reassure health system backers, patients, and the general population that 
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their money is being spent wisely and that resources are allocated optimally. These two 
concepts of efficiency and inefficiency may seem beguilingly simple. After all, these 
measures are frequently defined as a simple ratio of resources consumed to some measure 
of outputs that they create. Yet, despite its apparent simplicity, applying these concepts of 
efficiency in real-world settings can give rise to considerable complexity. This is 
especially true when examining efficiency in relation to the health system. All too often, 
measuring efficiency in this context reveals a number of complicated and interlinked 
processes which are difficult to evaluate and deem to be efficient or inefficient. In 
working with these concepts, it is helpful to start small, explain what efficiency and 
inefficiency mean in a certain context, and continue to expand upon an understanding of 
efficiency from this point. The following paragraph begins this process by outlining two 
very important terms in this field of research: allocative efficiency and technical 
efficiency.  
Processes in the health system may be identified as inefficient for two distinct, but 
related reasons. The first reason is that health system inputs such as expenditure or other 
resources may be directed towards outputs that are not viewed as priorities by society. 
For example, high-cost end-of-life cancer treatments may be beneficial for the individuals 
involved, but society may see this spending as generally wasteful and believe that it could 
be better spent elsewhere (Cylus, 2016). Economists refer to this concept as allocative 
efficiency (AE) and it is often quantified using the measure of quality-adjusted life years 
(QALYs) as a prime cost-effectiveness criterion for determining treatment. The second 
reason for inefficiency within health systems is that there could be a misuse of inputs in 
the process of producing valued health system outputs, leading to wasteful spending. An 
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example of this can be viewed with unnecessary duplications of patient medical tests that 
squander resources which could potentially be utilized more effectively elsewhere 
(Cylus, 2016). Economists refer to this concept as technical efficiency (TE). These 
comparative measures essentially indicate whether or not an entity is maximizing its 
outputs given a certain level of inputs. However, where AE is concerned with analyzing 
strategic choices of what outputs to produce or what inputs to consume, the prime interest 
of TE is in the operational performance of the entity. While these two forms of 
inefficiency may be different in their approaches, each of their analyses of health system 
performance is intended to offer insights into the success with which health system 
resources are transformed into physical outputs (i.e. patient consultations) or valued 
outcomes (i.e. improved health).  
An Analytical Framework for Thinking about Efficiency Indicators 
 Now that the principles of AE and TE have been identified and explained, a 
simplistic viewpoint of efficiency can be established. Adopted from the European 
Observatory on Health Systems and Policies’ 2016 “Health System Efficiency'' Report, 
Figure 3.1 below represents the ratio of inputs an organization consumes in relation to 
the valued outputs it produces (Cylus, 2016, p. 10). 
Figure 3.1: The naive view of efficiency 
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In this model, efficiency is determined using an economist’s “production function” 
mindset. A “production function” mindset is an economist’s view of the transformation 
of inputs into valued outputs. This mindset indicates the maximum feasible level of 
output for a given set of inputs. Within this thought process, any failure to attain that 
maximum efficiency level is to some degree an indication of inefficiency. While 
straightforward and easy to follow, this way of thinking represents nothing more than a 
partial measure of efficiency because the indicator shows only a fragment of the complete 
transformation of resources into the desired outputs.  
Especially when measuring health care systems, the majority of outputs rarely 
conforms to a production-line type technology in which a set of clearly identifiable 
outputs is used to produce a standard type of output. Instead, health care is designed to 
meet the specific needs of an individual patient, with various circumstances, preferences, 
and needs--ultimately leading to considerable variation in how inputs are consumed and 
outputs are produced. In light of these complexities, it is necessary to provide a 
framework for thinking more clearly about specific efficiency indicators and the respects 
in which each indicator may be informative, misleading, or partial. The five aspects of 
any efficiency indicator are: 1) the entity to be assessed; 2) the outputs (or outcomes) 
under consideration; 3) the inputs under consideration; 4) the external influences on 
attainment; and 5) the links with the rest of the health system (Cylus, 2016, p. 11). 
The beginning of an efficiency assessment first depends on establishing the 
boundaries of the entity under scrutiny. At one extreme, an analysis could be as micro as 
a single treatment. At the other extreme, an analysis could be as macro as an entire health 
system. Most often, however, efficiency measurement takes place somewhere in the 
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middle, where the actions of individuals or groups of practitioners, hospitals, or other 
organizations within the health system are to be analyzed and assessed. Despite this 
variation, almost all efficiency analyses rely on comparison--whether between entities or 
within a single entity for a certain time period. This means that it is of extreme 
importance that the entities being compared are legitimately similar. Efficiency 
comparison between a popular clothing firm and an internet start-up, a large hospital and 
a small primary clinic, and a country like the United States and that of Comoros--a 
volcanic archipelago off Africa’s east coast--is to some extent unfavorable and 
suboptimal. 
From this point, two fundamental issues need to be considered concerning the 
outputs under consideration within the efficiency analysis--specifically in regards to how 
these outputs should be defined and valued. It is most often agreed that health care 
outputs should be defined in terms of the health gains produced. These health gains are 
evidenced in a number of ways, but most often through diminishing rates of mortality, 
increasing rates of discharge, and more removed statistics like upturns in life expectancy. 
However, given the lack of routine information gathering and the challenging operational 
realities of this consensus, outputs are often defined in a different manner. In practice, 
analysts are often constrained to measuring efficiency on the basis of measures of 
activities. These measurements are frequently represented in the form of patients treated, 
operations undertaken, or outpatients seen. These general values are somewhat 
inadequate because they fail to capture the specificity, diversity, and quality of health 
care delivery, but there is not yet a viable alternative to using such measures.  
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Fortunately, determining the inputs under consideration within efficiency metrics 
is less problematic because they can be accurately measured and summarized in the form 
of costs. Nevertheless, even these agreed-upon measures can yield conceptual and 
practical difficulties. A fundamental decision that determines these difficulties is the level 
of disaggregation among the specified inputs. At one extreme, a single measure of 
aggregate inputs (in the form of total costs) can be used. The input side of efficiency then 
effectively becomes costs. This approach assumes that the entities under scrutiny are free 
to deploy inputs efficiently. However, in practice, some aspects of input deployment are 
beyond the control of the entity and can only be changed in the longer-term. This 
discrepancy leads to a misassessment of inputs for one or more of the entities. A similar 
but opposite issue occurs with labor inputs that can often be over-aggregated by different 
labor types depending on the circumstance (Cylus, 2016). 
These difficulties continue with inputs of capital whose misuse can be a major 
source of inefficiency. Yet, incorporating these measures of capital into analyses is 
challenging, rudimentary, and sometimes misleading. In practice, analysts often have to 
be ready to resort to very crude measures of inputs such as the number of hospital beds or 
floor space as a proxy for physical capital. In deciding which inputs should be under 
consideration, it is important to remember that all efficiency metrics should be developed 
according to the intentions of the analysis. Doing so helps to remedy some of the 
aforementioned issues. If the interest is in the narrow and short-term use of existing 
resources, then disaggregating inputs is advantageous to the analysis as a whole. If the 
interest is in a less constrained and longer-term analysis, then a single measure of total 
costs may be perfectly adequate for indicating the physical inputs of an entity. 
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 After satisfying these three aspects that make up what is considered a naive view 
of efficiency, it is important to consider two separate classes of factors that bolster 
efficiency analyses to make them more complete and comprehensive. One of which--the 
external determinants of performance--affects organizational capacity by influencing an 
entity beyond its control in the environment in which it must operate. These 
environmental factors include, but are not limited to, the severity of the disease of the 
patient, primary care organization structure, and local geography and settlement patterns 
(Cylus, 2016). There is often considerable debate as to what environmental factors are 
considered controllable and which should be included within an efficiency analysis. In 
the short-term, almost all input factors and external constraints should be fixed. In the 
longer-term, many can be changed depending on the level of autonomy. In many 
circumstances, it may be appropriate to consider efficiency metrics both with and without 
adjustment for external factors.  
Rounding out the last aspect of any necessary efficiency indicator is the need to 
consider an analysis’ links with the rest of the health system. This task is essential to 
develop a more complete efficiency analysis model. Scrutiny of a health system entity in 
isolation may ignore the important implications of the entity’s impact on whole system 
efficiency. For example, if a primary care practice is held to account by only metrics of 
cost per patient, it might improve efficiency by shifting costs to other agencies without 
actually making better use of available resources (Cylus, 2016). This reality should be 
accounted for in any assessment of efficiency and, in principle, it should be feasible to do 
within the analytic framework. However, this is rarely done in practice and consequently 
important for determining bias in efficiency assessment. 
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Unfortunately, it is almost impossible to completely and perfectly accommodate 
each of the aspects summarized above into a single efficiency metric. Regardless, it 
remains important for efficiency analysts to be aware of which factors are more likely to 
affect the integrity of the analysis as a whole and seek to offer guidance on the 
implications of serious omissions and weaknesses (Cylus, 2016). This framework, in 
accordance with countless others, embraces the challenges and imperfections of 
efficiency analysis, aiming to deconstruct efficiency metrics into a manageable number of 
issues to propagate future research rather than remain incapable of potential efficiency 
comparison. Figure 3.2 below summarizes and expands upon the more simplistic 
understanding of efficiency demonstrated previously by Figure 3.1. Similar to Figure 
3.1, this table was adopted from the European Observatory on Health Systems and 
Policies’ 2016 “Health System Efficiency'' Report (Cylus, 2016, p. 19), but provides a 
more complete and complex understanding of efficiency which may be used for 
comprehensive efficiency metric analyses. 
Figure 3.2: A more complete model of efficiency 
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Measuring Efficiency: Methods and Limitations 
 As mentioned previously, technical efficiency and allocative efficiency are 
essential for understanding inefficiency as they measure wastes of resources in their own 
distinct, but related manners. TE indicates whether an organization is maximizing its 
outputs given its chosen level of inputs, regardless of the value placed on those outputs, 
but AE indicates whether the value of the chosen outputs creates the maximum value to 
society. These economic concepts, despite their seeming complexity, offer the only 
current available unifying framework for assessing all the diverse objectives of health 
systems within an efficiency framework (Cylus, 2016). There are numerous metrics that 
utilize these economic concepts within their methodology to measure efficiency, but 
among the most common and established of these methods are Data Envelopment 
Analysis (DEA) and Stochastic Frontier Analysis (SFA). In fact, “Over 400 published 
applications have used these methods within health care settings over the past 30 years,” 
(Hollingsworth, 2016, p. 99). Both methods see efficiency as a simple relationship 
between inputs consumed and outputs produced and assess how effectively a unit of 
production, such as a hospital, uses its own inputs, such as staff and drugs, to produce 
outputs, such as patients treated. These analyses are especially important in the context of 
international healthcare efficiency because they provide perhaps the most reputable 
framework based on sound economic concepts and contribute transparent and potentially 
useful efficiency comparisons.  
In efficiency analyses, the main interest is typically the connection between inputs 
and outputs, and often the connection between costs and outcomes. DEA is a useful 
efficiency metric for researchers that makes use of linear programming methods to place 
Pfaehler 34 
weights on the inputs and outputs in order to measure how efficiently an entity is 
converting inputs consumed to outputs produced. Measurements using DEA typically 
show the entities in question in the best possible light. This favorable representation 
should be taken into account when trying to understand the outcomes of a DEA analysis. 
For a multiple output or multiple input firm--like a hospital treating different types of 
cases using numerous nurses and physicians, various equipment, and so on--an overall 
measure of a hospital’s TE requires summing these different inputs and outputs in some 
way. In other words, we must give weights to each of the inputs and outputs. Final 
efficiency measurements using DEA analysis metrics typically fall between 0 and 1, 
demonstrating the TE score for each entity. DEA is also potentially useful in measuring 
efficiency changes over time, often referred to as a Malmquist Index. Measuring changes 
over time, rather than simply providing a snapshot of efficiency, gives a more accurate 
picture of what is really happening across time from entity to entity (Hollingsworth, 
2016).  
Despite its potential successes, DEA analysis also has its fair share of 
shortcomings. The technique is deterministic and outlying observations are very 
important in determining the efficiency frontier--the threshold of entities that offer the 
highest expected return on inputs for a defined level of outputs. Therefore, when using 
DEA it is imperative to ensure like comparison between entities so as not to grossly 
misrepresent the outliers within question and skew the efficiency frontier generated by 
the metric (Hollingsworth, 2016). Similarly, DEA is sensitive to the number of input and 
output variables used in the analysis. Overestimates of efficiency scores can occur if the 
number of units relative to the number of variables used is small. Thus, a general rule of 
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thumb as determined by the EOHSP is that “the number of units used should be at least 
three times the combined number of input and output variables,” (Hollingsworth, 2016, p. 
104). Still, DEA remains by far the most common method for analyzing efficiency within 
healthcare settings as it has now been applied successfully hundreds of times within such 
contexts.  
Similar to DEA, SFA is a useful metric for researchers that uses its own 
methodology to measure the distance an entity such as a hospital is from a calculated 
efficiency frontier. However, rather than using mathematical programming, SFA uses a 
statistical regression analysis to complete such a task. In SFA, the usual statistical error 
term utilized in analogous regression equations is split into both inefficiency and error. 
Some view this distinction as a more precise measure of efficiency as it accounts for 
statistical noise--random irregularity researchers find in any real-life data (Hollingsworth, 
2016). These advantages, along with recent advances in modeling techniques and 
computing capabilities, are part of the reason why the use of SFA has received increased 
attention in the production of health care analyses over recent years. Nevertheless, as 
with DEA and every other known method of efficiency analysis, there are several 
downfalls. Estimating the production frontier of an SFA analysis requires all outputs--
such as cost, for example--to be meaningfully aggregated in a single measure. However, 
this mix between variables and producer characteristics can skew distribution, error 
terms, and ultimately lead to an over- or under-estimation of efficiency (Hollingsworth, 
2016).  
Adding to the complexity of efficiency analyses is the brutal reality that even the 
most respected analyses like DEA and SFA can be very challenging in an international 
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context. This is due in part to the seemingly endless variations across data sources and 
key differences in health system structures and practices. Even when this data is readily 
available, it can be extremely difficult to find compromises within the data that work to 
allow effective cross-country comparability. However, as mentioned in the EOHSP’s 
2016 health system efficiency report, it is: 
“almost certainly preferable to steer the health system with imperfect measures 
we have available, rather than to fly blind. In our view, efficiency analysis should 
be routinely embedded in all relevant functions of service delivery and 
policymaking. However, it is vital that decisions are taken in full recognition of 
the strengths and weaknesses of indicators, and that the search for improved 
metrics and better resources for comparison is pursued with vigour” (Cylus, 2016, 
p. 19). 
 
In fact, any potential metric of efficiency will have its limitations depending upon its 
framework. This should not intimidate us as researchers, but instead motivate us to 
improve our measures and continue to analyze the efficiency of healthcare systems. 
Especially in an international context, these studies are severely lacking which in-turn 
limits proposals of policies that are potentially beneficial for benchmarking and gauging 
the efficiency of different types of healthcare delivery. These policies have the potential 
to remedy struggling healthcare systems and improve the lives of the citizens who rely on 
them; yet they continue to be overlooked. In fact, a study highlighted by EOHSP shared a 
2008 review finding that out of all health care efficiency studies, only 4% were cross-
country analyses (Cylus, 2016). Despite recognition that such data are desirable to 
capture trends in efficiency, compare changes over time, and identify the causal effects of 
policies, there simply remains reluctance among researchers to attempt to compare the 
limited cross-country longitudinal health data currently available. 
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Reconciling these truths--the difficulties of studying efficiency, the limitations 
associated with international healthcare comparisons, and the emergence of promising 
analytical metrics such as DEA and SFA--is a challenging but necessary task if 
researchers and governments alike wish to improve the current understanding of 
healthcare efficiency. Even more so, as worldwide populations continue to grow and 
resources continue to diminish, there is an increasing need for every country to maximize 
their overall effectiveness in healthcare delivery. The unfortunate reality is that health 
systems are extremely complex and there is often no consensus on which countries 
perform most efficiently, which method is the most appropriate, or which health 
outcomes should be directly attributed to certain healthcare inputs. Nonetheless, it is for 
the same reason that the most highly valued metrics are those which allow at least 
somewhat valid comparisons across countries (Cylus, 2016, p. 159).  
In a perfect world, of course it would be prudent for countries to focus more on 
harmonizing and improving access to registry or hospital discharge level data. This is true 
not only at the micro level, but also at the macro level because it would allow for the 
control of potential confounders and ensure comparison across entities that are 
undoubtedly similar. It would be even more advantageous if countries could provide 
longitudinal data that allowed researchers to track changes in efficiency across time 
(Cylus, 2016). Sadly, these resources and databases simply are not available to us--at 
least not yet. Although, as data sources continue to gradually improve internationally, “it 
is only a matter of time when register-based monitoring will be a part of routine reporting 
and follow-up of the performance, effectiveness and efficiency of providers,” (Sund, 
2016, p. 73). Technical developments could likewise help to facilitate data availability in 
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the near future, but even without these advances the appeal of international comparisons 
of health care efficiency is clear--despite the many challenges. Until that time, 
researchers should focus less on trying to develop perfect models and instead focus on 
robust comparisons using multiple analytical approaches.  
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Chapter Four: Measuring International Healthcare System Efficiency 
Establishing a Comprehensive Framework for International Efficiency Analysis 
In the previous chapter, the five aspects of any efficiency indicator are outlined in 
detail. In every efficiency analysis, it is important to remember that we must identify: 1) 
the entity to be assessed; 2) the outputs (or outcomes) under consideration; 3) the inputs 
under consideration; 4) the external influences on attainment; and 5) the links with the 
rest of the health system (Cylus, 2016, p. 11). In the case of healthcare efficiency 
analyses, we must be even more precise and consistent in our identification of these 
varying parameters. Each of these aspects must be outlined--whether measuring 
healthcare efficiency within the context of EHR and HIE or within another context--
before beginning analysis in order to provide a clear and specific framework on which 
each efficiency indicator can be judged as informative, misleading, or partial. 
Any analysis begins by establishing the boundaries of the entity under scrutiny. 
This entity could be as micro as a single treatment or as macro as an entire health system. 
For the purposes of this analysis, data will be measured from the perspective of an entire 
health system and on a country-by-country basis. This type of analysis focuses on entire 
health statistics databases such as the World Bank, World Health Organization, United 
Nations, and--in this instance--the Organization for Economic Cooperation and 
Development (OECD). However, analysis of these health system entities--and thus the 
databases that measure them--will predominantly focus on efficiency within the context 
of the hospital sector within each given country. Therefore, a hybrid approach is assumed 
in this analysis with a focus on hospital care to combine the benefits of the OECD’s 
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reliable data with the advantages of statistically significant findings associated with 
subsector-level analysis approaches.  
The reason for this hybrid approach is due to the benefits and limitations 
associated with using DEA, SFA, or any other analysis metric in the context of healthcare 
efficiency. Employing these analyses with an emphasis on cross-country databases or a 
focus on system- or subsector-level approaches requires an understanding of how these 
analyses will stand in terms of internal validity, external validity, precision measurement, 
etc. Similar to analytic frontier methods--data analyses that establish a threshold of 
entities that offer the highest expected return on the inputs consumed--the factors behind 
these concentrations are nuanced and only increase in complexity when employed to 
measure efficiency internationally. To simplify the various qualities of analyses 
conducted with cross-country, system-, and subsector-level approaches, Table 4.1 
provides a summary of the examples, benefits, and limitations associated with each. This 
table is a shortened adaptation of its original version which can be found in the European 
Observatory on Health Systems and Policies’ 2016 “Health System Efficiency'' Report 
(Cylus, 2016, p. 160). 
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Table 4.1: Summary table of international efficiency indicators 
 
Using this table, we can establish and outline our analysis as an international 
comparison of the technical efficiency and productivity of the hospital subsector. Having 
now clearly identified the entity in question, it is imperative to identify the countries that 
will be measured under such a framework. For the purpose of this research project, the 
efficiency study assumes a fifteen-country analysis. This dataset should provide an 
extensive look into healthcare system efficiency for each country and serve as a 
resourceful tool for future researchers. These countries in question are: Australia, Canada, 
Denmark, France, Germany, Israel, Italy, Japan, Netherlands, New Zealand, Norway, 
Sweden, Switzerland, United Kingdom, and the United States. This analysis should be 
completed without making disparate or inappropriate comparisons across countries as 
each of these nations is comparatively modernized and industrialized with health systems 
that are unique, diverse, and rather high functioning. Any two of these fifteen countries 
could be chosen at random and compared to the other with little difficulty as each 
maintains a similar quality of life, economic development, health expenditure, and much 
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more. More importantly, each of these countries holds membership in the OECD and 
continuously updates database profiles that contain countless insights into the operational 
capacity of their respective healthcare systems. Finally, while the number of countries 
considered within the analysis could be increased to include other highly developed 
OECD nations, we instead chose to limit the number of countries to only OECD member 
states with well-documented histories of EHR and HIE implementation. Much of this 
history was provided thanks to The Commonwealth Fund’s International Health Care 
System Profiles in which each of the fifteen countries selected are included. 
Now that boundaries have been established for the entity and respective countries 
under consideration, two fundamental issues need to be carefully considered regarding 
the outputs associated with the analysis. It is most often agreed that health care outputs 
should be defined in terms of the health gains produced. However, this health gain data is 
almost never readily available which prompts researchers to instead use inpatient days or 
discharges as an intermediate form of output data. This analysis will focus on data 
pertaining to two of the most readily available intermediate outputs: discharge and 
mortality. Discharge rate is generally important because it documents how many 
individuals are successfully moving through the health system. More specifically, 
heightened discharge rates in the presence of EHR and HIE could be an indication that 
the technology is increasing a hospital sector’s capacity to treat more patients more 
quickly, thus increasing overall efficiency. The output of discharges is favored over 
inpatient days as unnecessary inpatient days may be a false indication of high hospital 
efficiency (Varabyova, 2013). For the purposes of this research project, discharge data is 
considered by diagnostic category, measured by density per 100,000 members of the 
Pfaehler 43 
population, and includes all diagnostic category causes. Mortality, the second health care 
output taken into consideration, captures the average in-hospital mortality rate as an 
additional variable to control for the potential tradeoff between inefficiency and death. 
Opposite to discharge rate, mortality rates are important because they provide 
information about how many individuals are unsuccessfully moving through the health 
system. This measurement represents a viable measure for hospital quality because it 
encompasses “effective medical interventions and [the] timely and coordinated treatment 
of patients,” (Varabyova, 2013, p. 74). Within this analysis, the in-hospital mortality 
output is maintained and measures the value in terms of rate per 100,000 hospital 
patients. Oftentimes, a lack of routine information gathering and the challenge of arriving 
at a consensus of output measurements in question poses problems for efficiency 
analyses, but these two outputs under consideration are commonly adopted within a 
number of current healthcare efficiency studies. 
The next phase of analysis turns to determining the inputs in question. These 
choices are less problematic within efficiency metrics because they are almost always 
accurately measured and summarized in the form of resource costs. At one extreme, a 
single measure of aggregate inputs (in the form of total costs) can be used. However, in 
this analysis the input variable of cost is adapted to accommodate a number of different 
common hospital resources: number of beds, total hospital employment, physician 
employment, and professional nurse and midwife employment. First, the number of 
hospital beds represents a measure of total hospital resources consumed. The number of 
beds is “conventionally used as an approximation for the capital and technology input in 
a within-country hospital comparison as well as in an international context,” (Varabyova, 
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2013, p. 74). Next, total hospital employment represents a head count of available 
medical personnel within a given hospital. This data is sometimes disaggregated by skill 
level--especially to differentiate between the availability of physicians or nurses and 
midwives--but total hospital employment remains a necessary input measurement to 
account for healthcare systems and entities that stray away from healthcare delivery via 
traditional hospital personnel. Nevertheless, given this analysis’ focus on OECD database 
metrics, physician employment as well as professional nurse and midwife employment 
are both considered as separate variables to deliver a more complete count of total inputs 
into each hospital-sector-focused measurement.  
Our analysis has now satisfied three aspects of what typically make up a naive 
view of efficiency: the entities, outputs, and inputs under consideration (pictured in 
Figure 3.1 of Chapter Three). Now, we must also consider two separate classes of factors 
that enhance the validity of any efficiency analysis. One of these factors, the external 
determinants of performance frequently referred to as environmental variables, affects 
organizational capacity by influencing an entity beyond its control in its operational 
environment. These environmental variables often include disease severity of each 
patient, primary care organization structure, and local geography and settlement patterns. 
For the purpose of this international efficiency measure, the analysis will include: 
healthcare expenditure, financing of health care, income inequality, market influences, 
education, length of stay, health status, patient mix, and full-time employment.  
The first of these external factors, healthcare expenditure, is absolutely necessary 
to measure as this data provides insight into not only what portion of the economy is 
dedicated to health funding, but also whether this dedicated funding is effectively 
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improving healthcare system performance to justify the cost. This measure is included in 
environmental variables and not input variables because it is not directly involved in the 
care delivery process in the same manner as total hospital beds, total hospital 
employment, etc. Instead, this variable is beyond the control of a hospital’s operational 
environment. In this study, healthcare expenditure is measured in terms of share of gross 
domestic product and includes all facets of spending--both public and private--in order to 
tailor the measurement to each country’s economy.  
Financing of health care is similarly important for complete and comprehensive 
analyses, especially because all OECD countries use different methods of financing their 
healthcare through both public and private sources. An analysis can control the effects of 
this mixed financing scheme by considering both the percentage of public and private 
financing. As mentioned by Varabyova, high levels of private spending can often lead to 
regressive health systems and lead to greater inequalities in health resource access (2013, 
p. 74). This analysis measures both of these financing methods separately, but in different 
ways due to limitations in data availability. Public financing is measured using the share 
of gross domestic product consumed by curative and rehabilitative care in hospital 
settings. On the other hand, private financing is measured using the share of current 
expenditure on health for voluntary schemes or out-of-pocket payment schemes. The 
units of measurements for the two variables of healthcare expenditure and financing of 
health care may appear to be different at first glance, but the second measure simply 
provides a more concentrated view of how current health expenditure is divided between 
public and private outlets.  
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The third environmental variable considered is income inequality because 
differences in income distribution “might affect health status and health care efficiency at 
the international as well as at the regional level,” (Varabyova, 2013, p. 74). This variable 
is recorded using the Gini coefficient which assumes a value from 0 to 1 in which a 
higher value represents a greater degree of inequality.  
Market influences are likewise included to account for competitive pressures 
within the health sector that could elicit faster adoption of technology or better capture 
economies of scale. These influences are typically measured using total hospital density 
as well as public hospital density to again emphasize the importance of considering 
mixed-scheme financing. Within the analysis, each of these measures are maintained and 
counted in terms of density per million population. 
The remaining environmental variables to be measured are equally as important 
for consideration within international healthcare efficiency analyses but differ slightly 
from those previously described as they focus more on country demographics and 
population health statistics. Education represents one of these variables and has proved to 
be a key contributing factor to empirical studies on health, influencing both quality of life 
and mortality rates (Varabyova, 2013, p. 74). As is common, this analysis measures 
education as the percentage of the population with a secondary education ages 25 to 64. 
Length of stay within hospital settings also represents another factor that differs 
considerably from country to country. Certain health systems may be structured so that 
hospital stays are less costly than others which allows providers to keep patients longer 
without fear of high expenses; this reality may lead to unnecessary inpatient days and a 
disproportionate increase in inefficiency. To help eliminate some of this nuance, average 
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length of stay for all causes is measured in days and included in the analysis. Health 
status is yet another measure that controls for the heterogeneity in population health 
status. Therefore, life expectancy is measured in years to characterize the quality of 
elderly care. On the other hand, infant mortality rate is measured in deaths per 1000 live 
births to assess the quality of prenatal care.  
The factor of patient mix is then included to continue with this demographic 
focus. Case-mix differences are almost always evident within empirical studies and 
hospital analyses should include some measure of the proportion of elderly patients. In 
this analysis, such a proportion is quantified by measuring the percentage of the total 
population 65 years old and older. Finally, full-time employment is included as the last of 
the environmental variables to account for what could be an overestimation of part-time 
labor input. This analysis takes into consideration the share of full-time employment in 
each country’s economy to control for the difference in working hours from one OECD 
country to the next. 
An analysis that satisfies each of these four aspects of efficiency indication 
provides a more complete view of efficiency. This is important within any efficiency 
analysis, but absolutely imperative for the validity of studies which aim to compare 
international healthcare systems. If any of these aspects differ to a considerable extent--
the entity in question, input variables, output variables, or environmental variables--
researchers will inevitably face difficulties in formulating reliable comparisons. Even 
having satisfied each of these components, yet another aspect must still be considered to 
provide an even more polished efficiency analysis model: the links an analysis shares 
with the rest of the health system. This aspect is important because scrutiny of a health 
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system entity in isolation has the potential to ignore the important implications of the 
entity’s impact on whole system efficiency. In principle, this aspect of analysis should be 
feasible to do within a given framework. An in-depth evaluation of health system 
operations within the context of EHR and HIE is provided in Chapter Six for several 
different countries. However, for the purposes of this research project, the analysis 
provided bypasses hyper-specific scrutiny of whole system efficiency to instead utilize a 
hybrid approach that focuses on subsector-based data made available by cross-country 
databases like the OECD. 
Measuring Efficiency within the Context of EHR and HIE 
As evidenced by preceding sections and chapters of this text, measuring 
efficiency from country to country is an extremely beneficial skill and useful tool for 
healthcare researchers, workers, and beneficiaries. To be able to measure efficiency 
within and between healthcare systems provides researchers with the insight they need to 
improve regional, national, and international care delivery. However, this understanding 
efficiency means very little in the context of this research project if it cannot be applied 
within the context of electronic health records and health information exchange.  
In order to accomplish this task, I performed a data analysis--more specifically, a 
stochastic frontier analysis--over a period of 18 years (2000 to 2017) to determine 
efficiency scores for each country and year. Efficiency scores were then compared on a 
country-by-country basis using the year that EHRs were introduced and the most current 
efficiency score available (2017). In almost all cases, there is no exact point in time when 
EHRs were introduced on a nationwide scale for a given country. Current literature 
exemplifies the slow-moving nature of EHRs thanks to high cost, reluctant adoptance, 
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and challenges in effective training and use so it is understandable that these initial dates 
of EHR implementation are somewhat fluid and open to educated interpretation. To 
accommodate for this obstacle, an estimated date was determined for each country. These 
dates, along with indexes of EHR adoption by country and extended explanations for how 
each date and index score was selected, are provided in more detail in Table 5.5 of 
Chapter Five. 
By comparing these efficiency scores through numerous time periods and across 
various countries, the hope is to gain a more precise understanding of not only whether 
EHRs have affected health system efficiency, but also at what point, to what degree, and 
in what aspects. This method represents the most inclusive analysis of EHR and HIE 
impact on international healthcare system efficiency. Efficiency analyses--and the scores 
that they determine--control for the majority of outside variables that might otherwise 
tarnish a study with bias. Comparing these values over time should provide a more telling 
representation of the impact EHRs have on each nation and the international community 
as a whole. 
Limitations: Methods 
There are countless obstacles to measuring and understanding the complex 
functions of healthcare and various healthcare systems, but one thing is absolutely 
certain: our methods can always be updated and improved. In a more perfect analysis, 
one might improve some of the variables under consideration--like disaggregating 
discharge data to classify discharges by diagnostic category. In doing so, this output 
could be made more extensive by including a shortlist of diagnostic categories or a global 
length of stay (LOS) measure. However, given the limitations of this research project, a 
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luxury such as this had to be sacrificed. In a perfect world, it would undoubtedly be 
prudent to focus on harmonizing data or going the extra mile to control for potential 
confounders. Sadly, this reality is not always attainable, but that does not discount the 
versatility and usefulness of methods such as this. In the future, developments in 
healthcare and economic research could help to facilitate new frameworks for thinking 
about and analyzing healthcare system efficiency--especially as it relates to new tools 
provided by HIE such as the EHR--but even without these advances this methodology 
has proved itself both thoughtful and extensive. As mentioned previously, it is less 
important for researchers to focus on trying to develop perfect models and more 
important to instead focus on robust comparisons using diverse analytical approaches and 
deliberate thought processes. 
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Chapter Five: Data and Analysis 
Justification for a Hybrid Stochastic Frontier Analysis (SFA) Approach 
In Chapter Four, Table 4.1 provides a summary of a number of different 
approaches for international efficiency measurements. Each of these examples--cross-
country, system-, and subsector-level approaches--brings its fair share of benefits and 
limitations to any efficiency measurement. For the purpose of this project, the following 
analysis combines different aspects of each of these approaches into a hybrid approach to 
create a more valid and reliable assessment of international efficiency. This hybrid 
analysis uses cross-country data from the OECD iLibrary Data Warehouse but does so 
with a system-level focus on hospital sector data to calculate an efficiency score for each 
country under consideration. The purpose of this mixed analysis is to combine the 
advantages of each type of approach and avoid some of the methods’ associated 
disadvantages. Advantages of this hybrid approach include: regularly-updated, reliable, 
and comprehensive data; the capacity to control for confounding variables to some 
extent; and the ability to effectively compare entire health systems. Likewise, some 
disadvantages this analysis tries to bypass include: weak associations between inputs, 
outputs, and expenditures; limited external validity; and an impeded focus on health 
outcomes as opposed to an assessment of health outputs.  
This hybrid approach to international efficiency measurement and the data 
associated with each of the inputs, outputs, and environmental variables under 
consideration is then regressed using Stochastic Frontier Analysis (SFA) in order to both 
understand how each input affects an associated output and to determine an overall 
efficiency score for each country. SFA was determined more appropriate than Data 
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Envelopment Analysis (DEA) for several reasons. First, DEA focuses on often 
complicated linear programming methods that must place weights on certain inputs and 
outputs. On the other hand, SFA uses statistical regression methods that combine all 
variables into a single aggregate measure. Additionally, SFA measures relationships 
between variables in ways that are often regarded as more user-friendly and easily 
understandable. An example of this is denoted in the Findings portion of this chapter as 
associated coefficients show the extent to which both the inputs and environmental 
variables affect each output. The last--and perhaps most influential--reason for choosing 
SFA over DEA was the availability of online resources and research professionals to help 
assist in completing such an analysis. Simply put, SFA appeared more appropriate for the 
purposes of this study. 
The analysis portion of this research project was conducted using STATA, a 
general-purpose statistical software package most often used for research in the fields of 
economics, sociology, political science, biomedicine, and epidemiology (Stata, n.d.). I 
was instructed on how to use this software package for basic regression analyses, 
conducting t-tests, extrapolating graphs and charts, etc. in one of my undergraduate 
courses. However, given the hyper-specific nature of DEA and SFA analyses as well as 
their importance in this area of study, I thought it best to reach out to several 
professionals for assistance in completing my efficiency analysis. After several 
unsuccessful attempts to locate and secure assistance from faculty, I solicited the help of 
a third-party postdoctoral researcher who aided my completion of the SFA analysis.  
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Findings: Output 1 
Table 5.1 and Table 5.3 show the results of this analysis as each table presents 
the Input and Environmental Variables’ coefficient scores in relation to Output 1 and 
Output 2. Similarly, Table 5.2 and Table 5.4 represent efficiency scores for each country 
in relation to Output 1 and Output 2. These efficiency scores represent technical 
efficiency benchmarks where 1.000 is completely efficient (more favorable) and 0.000 is 
completely inefficient (least favorable). The Do Files used to inform these STATA 
commands can be located in the Appendix chapter. The findings resulting from this data 
analysis using these commands are found below. Again, the results of Output 1 are 
important because discharge rate more or less documents how many individuals are 
successfully moving through the health system. In the case of EHR and HIE, heightened 
discharge rates could be an indication that the technology is increasing a hospital sector’s 
capacity to treat more patients more quickly, thus increasing overall efficiency. 
Table 5.1: Stochastic Frontier Analysis Coefficients, Output 1 
Stochastic Frontier Analysis 
Output 1: Log Discharge Rate By Diagnostic Category, All Causes 
(Per 100,000 Population) 
VARIABLES COEFFICIENT 
INPUTS   
1) Total hospital beds (per 1000 pop.) 0.081*** 
2) Total hospital employment (per 1000 pop.) -0.012*** 
3) Physicians employed in hospitals (per 1000 pop.) 0.154*** 
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4) Professional nurses and midwives employed (per 1000 pop.) -0.004*** 
ENVIRONMENTAL VARIABLES   
1) Health expenditure (share of GDP) 0.006 
2) Expenditure on curative and rehabilitative care (share of GDP) 0.064 
3) Household out-of-pocket payments (share of health exp.) -0.005* 
4) Income inequality (Gini coeff.) 4.335*** 
5) Total hospitals (per million pop.) 0.007*** 
6) Publicly owned hospitals (per million pop.) -0.002 
7) Upper secondary education (per 1000 pop.) -0.000 
8) Average length of stay, all causes (days) 0.054*** 
9) 65 years old and over (% of total pop.) -0.020*** 
10)         Life expectancy at birth (years) -0.022 
11)         Infant mortality (deaths per 1000 live births) -0.071* 
12)         Incidence of full-time employment (share) -0.004 
Notes: ***Significant at the 1% level; *Significant at the 10% level 
When working with data analysis of any type, one factor is always important in 
determining the validity of a given set of results: statistical significance. As evidenced by 
the table above, all four input variables were found statistically significant in influencing 
Output 1, the discharge rate. Given this information, we can confidently move on to 
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analyzing our coefficient score to better understand how each of these variables 
influences Output 1. Examining the coefficient score for Input 1, one can resolve that if 
the total number of hospital beds increases by 1 bed per 1000 population, the discharge 
rate increases by .081 discharges per 100K population. Likewise, if the number of 
physicians employed increases by 1 physician per 1000 population, the discharge rate 
increases by .154 discharges per 100K population. However, one can also conclude that 
the total hospital employment and the number of nurses and midwives employed decrease 
the discharge rate significantly. While this only occurs to a very marginal degree, (.012 
and .004, respectively) this information is still meaningful in determining how one 
variable impacts another. Switching focus to the environmental variables, one can 
conclude that income inequality, total hospitals, and average length of stay each 
significantly influence efficiency in a positive manner (by 4.335, 0.007, and 0.054 
coefficient points respectively). On the other hand, a higher proportion of older people 
and a higher infant mortality seem to reduce efficiency (by 0.020 and 0.071 coefficient 
points, respectively). Meanwhile, other variables such as the number of total hospitals is 
significant at the 10% level. While this determination may still influence our view of how 
certain variables impact the rate of discharges or the overall efficiency, it is not 
economically meaningful.  
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Table 5.2: Efficiency Scores by Country and Year, Output 1 
 
 
Table 5.2 provides efficiency scores for each of the countries under consideration 
for any given year between 2000 and 2017. In cases where efficiency scores are missing, 
it is due to a lack of data available to complete the statistical regression. This data is most 
often lacking in the Input category but is occasionally absent for environmental variables 
as well. This hindrance is explained in more detail in the Limitations section of this 
chapter. Nevertheless, it appears as though both the United States and Norway exhibit the 
highest overall efficiency scores for any country examined within the analysis--although, 
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it is important to note that the last seven years are missing efficiency measures for the 
United States. Therefore, it remains somewhat unclear whether the United States can be 
viewed as more efficient than Norway, Israel, or a handful of other countries within the 
analysis. Additionally, it is remarkable that several countries achieved a maximum 
efficiency score of 1.000 and were considered at the benchmark efficiency level for 
healthcare efficiency over any extended period of time. However, given the number of 
efficiency scores missing within this portion of the analysis, it can be concluded that the 
measure possesses a rather weak validity. 
Findings: Output 2 
 Table 5.3 was arranged using the same methods as Table 5.1. Thus, the values 
found within this table can be interpreted in a similar manner. The only difference worthy 
of notation for interpreting these coefficient scores is the switch from Output 1, 
measuring the discharge rate, to Output 2, measuring the average in-hospital mortality 
rate. 
Table 5.3: Stochastic Frontier Analysis Coefficients, Output 2 
Stochastic Frontier Analysis 
Output 2: Log Average In-Hospital Mortality Rate 
(Per 100,000 Patients) 
VARIABLES COEFFICIENT 
INPUTS   
1) Total hospital beds (per 1000 pop.) 0.013*** 
2) Total hospital employment (per 1000 pop.) -0.003 
Pfaehler 58 
3) Physicians employed in hospitals (per 1000 pop.) -0.128*** 
4) Professional nurses and midwives employed (per 1000 pop.) 0.022** 
ENVIRONMENTAL VARIABLES   
1) Health expenditure (share of GDP) -0.000 
2) Expenditure on curative and rehabilitative care (share of GDP) -0.000 
3) Household out-of-pocket payments (share of health exp.) -0.000 
4) Income inequality (Gini coeff.) 0.000*** 
5) Total hospitals (per million pop.) 0.000* 
6) Publicly owned hospitals (per million pop.) 0.000 
7) Upper secondary education (per 1000 pop.) -0.000 
8) Average length of stay, all causes (days) -0.000*** 
9) 65 years old and over (% of total pop.) 0.000* 
10)         Life expectancy at birth (years) -0.000*** 
11)         Infant mortality (deaths per 1000 live births) -0.000** 
12)         Incidence of full-time employment (share) 0.000 
Notes. ***Significant at the 1% level; **Significant at the 5% level; *Significant at the 10% level. 
As evidenced by the table above, the number of hospital beds and the number of 
physicians employed significantly influence the average in-hospital mortality rate. If the 
total number of hospital beds increases by 1 bed per 1000 population, the mortality rate 
increases by .013 mortalities per 100K population. However, if the number of physicians 
Pfaehler 59 
employed increases by 1 physician per 1000 population, the mortality rate decreases by 
0.128 mortalities per 100K population. Therefore, investing in human resources in 
hospitals such as physicians employed is very important. Unfortunately, when we 
observe relationships among the environmental variables, it is clear that the analysis does 
not hold the same internal validity as that of Output 1--and it is less likely to maintain any 
sort of external validity. This low level of internal validity is likely due to large 
collinearity, missing values, and an overall low sample size of panel data available. 
Ultimately, while some of these input and environmental variables are found to be 
significant, none of them are economically meaningful at the three decimal point level. 
 
Table 5.4: Efficiency Scores by Country and Year, Output 2 
 
The abundance of variables exhibiting almost no correlation displayed within the 
findings of Table 5.3 forecast the rather meaningless efficiency scores provided in Table 
5.4. These efficiency scores do not differ at all at the three decimal point level. While 
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they do differ at lower levels, this variation is almost completely insignificant. It is clear 
that the efficiency analysis for this outcome is neither statistically nor economically 
meaningful. A detailed explanation for this adverse outcome is provided in the 
Limitations section below. 
Findings: Efficiency Scores in the Context of EHR and HIE 
 Given the unfavorable results highlighted in Table 5.4 of this data analysis, 
measurement of the effects of EHR and HIE on international healthcare system efficiency 
will proceed using only the efficiency scores found in Table 5.2. Of course, as mentioned 
previously, these effects will be calculated by measuring the change in efficiency over 
time for each of the countries under consideration. The first date used in measuring the 
difference in efficiency scores will be determined using the initial date of EHR program 
or legislation implementation in each country. Therefore, this date will vary by country 
and may be open to interpretation in certain circumstances. The second date used in 
measuring the difference in efficiency scores remains fixed for the year 2017--the most 
up-to-date efficiency score capable of being measured given available OECD data. Each 
of the initial dates for EHR implementation for each respective country is outlined in 
Table 5.5 below. In addition to this date, the table provides the respective name of the 
EHR program or legislation as well as an index score for each country. Similar to the task 
of determining the initial date of EHR implementation, the index score is determined in a 
manner that is somewhat open to interpretation. However, justifications for each score are 
provided within the table. Each of these decisions were informed by current literature as 
well as an assessment of current EHR adoption relative to other countries considered 
within the analysis.  
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Table 5.5: EHR Index, Implementation, and Adoption by Country 
Countries 
Date of 
Implementation 
Name of EHR 
Program/Legislation Reasoning for Index Score 
Australia 2012 My Health Record 
➢ Currently beginning opt-out due to security 
concerns 
Canada* 2001 Infoway ➢ Lacking adoption in hospitals 
Denmark 2007 E-Journal 
➢ Does not exist as a national EHR, but instead as 
a means of data empowerment 
France* 1998 Carte Vitale 
➢ High interoperability, adequate adoption rates, 
and plans to extend to social sector in the future 
Germany 2004 EHC, GMG 
➢ Does not exist as an EHR, but instead as a smart 
card 
Israel 2012 - 
➢ Strong implementation with plans for increased 
interoperability 
Italy 2012 InFSE 
➢ Average implementation with plans to slowly 
connect interregional EHRs 
Japan* 2002 - 
➢ Very little  progress in implementing a non-
experimental national EHR 
Netherlands 2011 AORTA 
➢ Plans to grow eHealth programs continue to 
remain in developmental stages 
New Zealand 1980 
Health Information 
Platform (HIP) 
➢ Four regional systems that operate 
independently without interoperability 
Norway 2008 
Summary Care 
Record (SCR) 
➢ History of high adoption, usage, and consistent 
improvement 
Sweden  2009 
National Patient 
Summary (NPÖ) 
➢ All 21 regions have provided citizens with access 
to a national EHR since EHR was adopted 
Switzerland 2015 LCIP 
➢ Recently implemented with anticipation of slow 
adoption 
United 
Kingdom* 2015 NHS App 
➢ EHR abandoned early, patient record now 
linked only through NHS App 
United 
States* 2009 HITECH Act 
➢ Development of Meaningful Use standards, 
eightfold increase in use since EHR 
establishment 
Notes: *Countries outlined in Chapter Six: Case Studies by Country; Legend located below. 
 
Very Strong 
Implementation 
Strong 
Implementation 
Average 
Implementation 
Weak 
Implementation 
Very Weak 
Implementation 
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Now that each country has an identified date of initial EHR program or legislation 
implementation, the efficiency change over time can be measured and analyzed. The 
results for this calculation are provided in Table 5.6 below. 
Table 5.6: Change in Efficiency Over Time 
 
 These results are admittedly suboptimal in the grand scheme of determining the 
long-term effect that EHRs and HIE have on international healthcare system efficiency. 
Of the results, two of the countries--France and Germany--show positive increases in 
efficiencies over an 18- and 14-year time period, respectively. Conversely, six of the 
countries--Denmark, Israel, Italy, Netherlands, Norway, and Switzerland--demonstrate 
negative declines in their efficiencies with an average time period of almost 8 years 
between EHR implementation and current modern-day use. The remaining countries 
under consideration--Australia, Canada, Japan, New Zealand, Sweden, the United 
Kingdom, and the United States--all remain undetermined in terms of measuring their 
change in efficiency over time. Two of these nations--Canada and the United States--
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provided a handful of efficiency scores over the 2000 to 2017 time period, but each of the 
other countries yielded no results for any of the years in question. Explanations for these 
deficiencies are outlined in the following section and Chapter Seven. However, this data 
analysis seems to raise more questions about both the long-term efficacy of EHRs and the 
feasibility of performing international healthcare efficiency analyses than it does affirm 
optimistic sentiments about health information technology as a whole. 
Limitations: Findings 
There are a number of limitations that could and should be addressed in an 
analysis such as this to improve its validity and comprehensiveness for the future. One 
can begin at the very beginning with the difficulties in measuring a rather new topic such 
as electronic health records and health information exchange. As with any new 
technology, there are limitations in measuring when it was implemented, to what degree, 
and to what level of success. Even more complicated is the fact that the idea of EHR 
implementation has been an issue that numerous countries have wrestled over for years. 
Some countries have even moved forward with EHR implementation for a number of 
years before deciding to abandon the program entirely--an example of this action is 
touched on and explained in detail in Chapter Six with the case of the United Kingdom. 
Continuing on with the limitations of this data analysis, it is important to think 
back again on the limitations of efficiency study in the first place. There is almost no 
consensus on how exactly it should be carried out, which entities should be included, or 
what variables should be under consideration. Even more troubling is the prospect of 
conducting an efficiency analysis from an international perspective where even more 
challenges and nuance begin to intertwine with each step of the analysis. Countries must 
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be proven--at least to some degree--demographically, politically, and economically 
similar. Without satisfying this requirement, the data input into any analysis can be 
skewed or tarnished with bias altogether.  
If each of these fundamental prerequisites are satisfied, the most insurmountable 
obstacle of them all--data availability and collection--waits in the wings for researchers to 
battle fruitlessly. Data availability and collection are impediments that researchers must 
deal with in almost every investigative or analytical scenario, but even more so in the 
case of international analyses of healthcare and healthcare efficiency. Data sources are 
often numerous, but frequently lack comprehensive longitudinal data for even a third of 
the countries around the globe that could otherwise be more appropriately studied and 
understood. When this data is rarely available, it almost never satisfies the needs of 
programs that demand thousands of observations in order to determine causality, prove 
statistical significance, and yield acceptable standard deviations. For example, even in the 
case of Output 1, which provided the most significant results of this analysis, there 
remain a myriad of missing values in the dataset. As a result, more than a third of the 
available efficiency scores are missing within this study--and five of these countries are 
missing scores in their entirety.  
Even when these countries and a majority of their input, output, and 
environmental variables are accounted for and reported, there still remains a serious 
statistical issue of small sample size. Statistical regressions, especially those of the more 
complex variety like SFA and DEA, rely on large sample sizes in order to calculate 
statistically significant values like the coefficient and efficiency scores. In the case of this 
analysis, 15 countries were measured using 4 input variables, 2 output variables, and 12 
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environmental variables over an 18 year period (2000-2017). Altogether, these variables 
numbered more than 270 unique observations. Even with somewhat large sects of 
missing data, no variable within the data set ever contained less than 153 observations. In 
fact, only three of the variables ever dipped below 195 individual observations--and still, 
much of the analysis calls for more data. This reality only brings about additional nuance 
and unforeseen complications as there exists only a handful of always unfavorable 
solutions: add more variables, include more countries, or measure more years. Yet, 
adding more variables would increase the potential for collinearity--a problem that would 
only bias efficiency estimates and unintentionally increase standard deviations. Similarly, 
measuring over a longer time period would be equally difficult because of the lack of 
data. In almost all scenarios, if data is not available from 2000 to 2017, there is little 
chance it will be available from 1980 to 2000. Lastly, including more countries would 
draw attention back to the fundamental requirement of only measuring countries 
comparable in likeness. Additionally, this impractical solution would only augment the 
difficulties of assessing EHR implementation and environmental variables within the 
country which allow each healthcare system to be financed, operated, and improved.  
 The study of international healthcare efficiency appears to be fighting an uphill 
battle on many different fronts. From understanding new technological implementation 
standards to developing and defining standards for healthcare efficiency to locating and 
analyzing large amounts of data that arrive at statistically significant findings, there 
seems to exist no limit on the number of obstacles healthcare researchers and 
professionals must overcome in order to arrive at meaningful conclusions. Even pre-
existing analyses to use as a basis for comparison are almost entirely outdated or 
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impossible to find. Still, insightful research in any and all areas of healthcare remains 
absolutely necessary in the coming years and decades in order to overcome future health 
challenges and dissipate some of the nuance surrounding some of healthcare’s most 
convoluted spheres. In the following section, some of this nuance is tackled head-on by 
outlining specific EHR implementation histories and outcomes for 5 of the 15 countries 
under consideration.  
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Chapter Six: Case Studies by Country 
 As evidenced by the data measured and analyzed in the previous chapter, each of 
the 15 countries included in this study demonstrate varying levels of increasing or 
decreasing technical efficiency within their respective healthcare systems. The majority 
of these countries actually show indeterminate results regarding their healthcare systems’ 
gains and losses in efficiency as the result of implementation and utilization of EHRs and 
HIE, proving the efficacy and future of these technologies somewhat inconclusive. 
However, one thing is certain: each nation employs this technology differently.  
Some countries began experimenting with the foundational basics of an EHR 
early on by incentivizing their patients to access and update their medical information 
through the internet. Others still face challenges in implementing these technologies due 
to issues with interoperability, security concerns, and decentralized healthcare systems. 
These country-to-country variations are to be expected in international comparisons, but 
it remains important to highlight these differences to show how this technology is being 
employed differently to yield effective or ineffective results. Five countries--Canada, 
Japan, France, the United Kingdom, and the United States--are chosen from the 
comparison not only to serve as representations of the group as a whole, but also to 
provide distinct examples of these varying levels of EHR implementation. In addition to 
their own distinct healthcare systems, each of these countries possesses a unique history 
of EHR adoption, utilization, and effectiveness. An understanding of these characteristics 
may help countries better identify how to implement these health records more 
efficiently--or not at all--both now and in the future.   
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Case Study 1: Canada 
 When thinking of Canada’s contributions to the world, it seems difficult to stray 
away from popular topics like maple syrup, hockey, and Tim Hortons--but in the realm of 
healthcare, Canada has quite a bit to offer healthcare researchers. The nation is 
representative of many of the countries utilized within this analysis and uniquely 
highlights both an interesting healthcare system and history of EHR use. Canadian 
healthcare was founded and designed so that “all insured persons have access to 
medically necessary hospital and physician services on a prepaid basis,” (Government of 
Canada, 2011). Similar to the United States, this insurance system is financed both 
publicly and privately. An estimated 69.8% of total health spending in Canada comes 
from public sources (CIHI, 2016). These expenses are funded primarily through the 
federal government’s contributions to the provinces and territories on a per capita basis. 
Nevertheless, private insurance is quite common as well and nearly ⅔ of Canadians 
maintain coverage for services typically excluded from public reimbursement like vision, 
dental, and rehabilitative care (Canadian Life and Health Insurance Association, 2015). 
Canada’s experiences with electronic health records began at the turn of the 
century. In an effort to improve both the patient experience and unlock sources of value 
for the health system, the Canadian government made the decision in 2001 to create 
Canada Health Infoway Inc. (Infoway). This not-for-profit private corporation describes 
its role as that of a “strategic investor” to accelerate the development of electronic health 
records across the country. Infoway was specifically charged with developing and 
implementing several types of digital health solutions including laboratory information 
systems, diagnostic imaging and drug information systems, and interoperable electronic 
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health registries and records. By March 31st, 2009, Infoway had spent nearly $615 
million and committed another $614 million (approximately $1.2 billion in total) to the 
EHR initiative (Office of the Auditor General of Canada, 2010). Fortunately, the venture 
has proven fruitful for the Canadian government. A 2009 report from the Auditor General 
of Canada found that Infoway’s EHR initiative showed “due regard” for taxpayers’ 
money and outlined a number of pathways to continue to improve the program. Even 
more indicative of Infoway’s success was a recent study done to test the initiative’s 
effectiveness. This study by PricewaterCoopers LLC found that, between 2006 and 2012, 
the increased use of electronic medical health records saved $1.3 billion--nearly $800 
million in administrative efficiencies and $584 million in health system benefits 
(avoiding duplicate diagnostic tests, improving chronic disease management, improving 
communication across providers, etc.) (CBC News, 2013).  
Canada Health Infoway’s success is certainly praiseworthy--and some countries 
may find its success deserving of use as a blueprint for the development of other EHR 
systems--but there remains no national strategy for implementing EHRs.  Instead, each 
province's systems remain somewhat divided in collecting data and sharing it 
interoperably throughout the country. And while EHR use more than doubled from 2006 
to 2012 (CBC News, 2013), by 2014 only 42% of general practitioners reported using 
EHRs to enter and retrieve clinical notes and 38% still claimed to use a combination of 
paper and electronic charts. In the same survey, 87% of general practitioners reported that 
their patients do not have access to their own personal health record and only 6% of 
patients have the ability to request appointments online (Allin, n.d.). Compiled with the 
fact that hospital setting implementation of EHRs remains abysmally low, it appears as 
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though Canada is still struggling with its fair share of problems with health information 
exchange implementation. This may be evidenced by Canada’s overall efficiency score of 
0.633, ranking second to worst behind the Netherlands of the ten countries displaying 
overall scores. Even taking into consideration the fact that Canada only exhibited scores 
for four of the eighteen years, it is disappointing that the country only showed a 0.007 
increase in efficiency from the year 2005 to 2017. Nevertheless, given the country’s 
recent history of financial success utilizing HIE, Canada provides an optimistic outlook 
for the future of EHR development and certainly has more to provide international 
healthcare researchers than a tasty coffee and doughnut. 
Case Study 2: Japan 
 With an incredibly developed and industrialized society as well as an increasingly 
aging population of more than 127 million people, Japan provides one of the most 
prudent healthcare system examples in the world. The Japanese possess what is known as 
a Statutory Health Insurance System (SHIS) that provides universal primary coverage 
and comprises more than 3,400 noncompeting public, quasi-public, and employer-based 
insurers. The national government sets provider fees and subsidizes care through general 
tax revenue and insurance contributions. Primary care is typically provided in private 
nonprofit hospitals which account for approximately 80% of beds while public hospitals 
round out the other 20% (Matsuda, n.d.). This combination of funding and treatment 
options have boded well for the nation. The government has long boasted the 
affordability and first-class nature of its healthcare system. In fact, Japan has consistently 
remained atop the world rankings with its high life expectancy. In 2017, the OECD 
ranked the average lifespan in Japan first in the world at 84.2 years. This area of care 
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delivery is where Japan’s future in healthcare becomes truly intriguing--and, frankly, 
worrisome.  
In addition to the country’s excellent life expectancy, Japan’s healthcare system is 
also regarded as one of the world’s most favorable because it maintains rigorous price 
controls on cost of care, medications, and surgical procedures to protect its citizens. The 
country upholds a strict requirement that hospitals remain nonprofitable, so the majority 
of public hospitals continually operate at a deficit. Some might see little problem with 
this arrangement, but Japan’s increasingly aging population appears to be placing the 
nation’s already strained system under more pressure than ever. In an article from The 
Japan Times, one writer highlights how Japan ranks third highest in health spending as a 
percentage of GDP, trailing only the United States and Switzerland. Quoting Yusuke 
Tsugawa, a physician and research associate at Harvard University specializing in health 
care economics, the article adds that “...while the government controls the cost of medical 
goods and services, it doesn’t control the volume of the services provided...This has 
fostered a culture in Japan of patients seeking more care than necessary because access is 
unlimited,” (Otake, 2017). Unfortunately, as the Japanese population continues to grow 
and the nearly 26% of its citizens aged 65 or older grows to nearly 33% by 2050 (ILC 
Japan, 2013), healthcare system sustainability is only going to grow increasingly more 
uncertain.  
One might certainly find Japan’s healthcare worries a prime opportunity to 
implement innovative technology like EHRs and HIE to help solve this potentially costly 
development. In fact, looking to get ahead of problems looming on the horizon, Japan 
initially attempted EHR adoption in the latter half of the 1990s, but it was not until 2002 
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that the EHRs became more widespread (Tanaka, 2007). EHRs have been developed and 
experimented in select areas in the years following this movement, but since momentum 
faltered around 2006 a national system has yet to be established or implemented on a 
comprehensive scale. Unsurprisingly, interoperability between providers at the local and 
regional levels was also overlooked. The government maintains that experiments are 
currently underway to make HIE available to patients and providers via cloud computing 
which would give patients access to features like unique identifier numbers and Social 
Security and Tax Number Systems. Initiated in 2016, these efforts were scheduled to be 
phased into healthcare delivery networks by 2018 (Matsuda, n.d.). Supporters of EHR 
systems may find this news promising, but the reality remains that Japan is very far-
removed from meaningful health information exchange.  
The turbulent nature of Japan’s EHR history and the lack of information regarding 
the country’s healthcare efficiency score lends little information as to why Japan 
continues to demonstrate interest in reviving its once-failed healthcare technology. After 
all, their attempts appear more like efforts to resuscitate a lifeless EHR program than they 
do pursuits to bolster an already effective healthcare tool--which begs the question why 
Japan has continued to invest in EHR and HIE? This persistent, albeit lackluster, 
endeavor could exist thanks to techno-optimist sentiment in one of the world’s most 
technologically advanced countries. Perhaps these actions may be the result of the 
foresight of policy experts and medical professionals who visualize the looming threat of 
population aging on the horizon. Or, as some researchers claim, this may be due to 
Japan’s historic compulsion to maintain the “status quo” and avoid the embarrassment of 
failing to “maintain the high standards of medicine now in use in Japan,” (Yoshihara, 
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1998). Justification for each of these speculative reasons remains somewhat unfounded; 
yet, it remains clear that EHR and HIE technologies are tools that countries like Canada 
and Japan continue to invest in despite their questionable practicalities and benefits.   
Case Study 3: France 
 It is nearly impossible to have a conversation about electronic health records and 
health information exchange without discussing France. The country first began 
experimentation with an EHR in 1998 when it launched the Carte Vitale, a health 
insurance card intended to allow patients to settle directly with the medical arm of the 
social insurance system (Brieu, n.d.). Since then, the country has led the charge 
internationally in health information exchange by attempting to expand upon its original 
Carte Vitale with the Carte Vitale 2--a similar smart card carrying a picture for 
identification and the ability to store electronic documents. Even more impressive was 
the country’s lofty goal to expand computer-based medical efforts in 2004 with its 
“Dossier Médical Personnel, DMP” (known as the “Dossier Médical Partagé” since 
2015) which is a “digital health booklet that stores and secures your health 
information...It allows you to share them with the health professionals of your choice, 
who need to care for you” (DMP France, 2020). The DMP was created with the hope that 
an EHR system would help increase communication and transparency and improve 
overall quality of care, but it was not long until France ran into problems with 
longitudinal paper records and patient security. The project looked defeated when the 
government failed to make the DMP fully operational by its goal of 2007, but soon 
gained new life when the French national legislature and Ministry of Health relaunched 
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the project with full support in 2011 (Stone, 2014). The system has since grown in 
operational ability and approval. 
Admittedly, EHR adoption rates in France were only measured at 67% for 
physicians (Stone, 2014). However, the capabilities of the DMP make it one of the most 
adept in the world. With the Dossier Médical Partagé, patients not only have access to 
their own unique electronic identifier number, the ability to make appointments easily 
online, and a personalized patient portal, but they also have the ability to allow any health 
professional or facility access to their medical record for consultancy and treatment of 
any kind. This level of unparalleled interoperability is ensured through the chip on each 
patient’s Carte Vitale health card and endorsed thanks to France’s centralized top-down 
driven governmental system.  
France has a stronger hold on privacy laws than most other nations which allows 
the country to bypass rules and regulations that would normally overemphasize privacy 
concerns (Stone, 2014). This governmental structure provides the perfect foundation for 
future EHR systems to successfully connect and operate with advanced capabilities like 
increased interoperability and clinical decision support (CDS). Interoperability between 
health and social care professionals has not yet been permitted (Durand-Zaleski, n.d.), but 
this level of exchange of information is unheard of elsewhere in the world and appears to 
have yielded dividends for France’s healthcare efficiency as of late. This is evidenced by 
the country’s 0.091 increase in efficiency over the eighteen year period and the 0.115 
increase from 2015 to 2016, in particular. While these increases have only been 
witnessed recently, this development is promising for the future of EHR in France and 
elsewhere throughout the world. France’s recent success in EHR gains and continued 
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pursuit of HIE diversification exemplifies why other nations like the United States should 
look to France for help in creating more robust, adaptable, and interoperable HIE systems 
for the future.  
Case Study 4: United Kingdom 
 Created in 1948 following the end of World War II, the United Kingdom’s 
National Health Service (NHS) represents the world’s oldest universal healthcare system 
(Brain, n.d.). Since it was founded, the NHS has prided itself on providing free coverage 
at the point of need to all eligible citizens. These services are traditionally financed 
through taxes, and citizens have experienced increased taxation for health services since 
the 1980s as health expenditure has continued to trend upward. Today, the NHS promises 
more information, resources, and healthcare employees for patients while continuing to 
combat long wait times, high accident and emergency (A&E) department costs, and a 
fast-aging population. 
 The United Kingdom’s history with EHRs is equally as interesting as it is 
complicated. In 2002, the UK government launched the development of the NPfIT 
otherwise known as NHS Care Records Service. This program was intended to deliver an 
EHR system that could store and share patient records from across the UK. However, 
there were soon numerous problems relating to poor user accessibility, failures in 
addressing patient confidentiality, overambitious timescales, and enormous cost overruns. 
In 2008, the Summary Care Record (SCR) was introduced and headed by the NHS with 
the intention of its use as an EHR in emergency or out-of-hours care settings. By 2011, 
the NPfIT was dismantled almost entirely and the SCR was named the focus of the NHS. 
However, shortly after, the SCR also dealt with similar shortcomings and the UK 
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abandoned their pursuit of a national EHR and instead shifted focus from HIE 
implementation on a national scale to management and use by individual general 
practitioners (GPs).  
Since April 2015, these GP practices have been obligated to offer patients the 
option to book appointments and request prescriptions online. These requirements were 
expanded in 2018 to include offering patients information about their diagnoses, 
medications, treatments, immunizations, and test results. An NHS App was even 
developed and rolled out in January 2019 (NHS England, 2019). The app is designed to 
give patients an additional resource to access their medical records, book appointments, 
refill prescriptions, and manage their long-term conditions (Australian Digital Health 
Agency, n.d.). Despite these successes, SCR records are never linked between GPs or 
other providers and the UK still lags far behind their goal of reaching digital maturity for 
their patients. NHS patients continue to find themselves unable to secure digital copies of 
their health records, and while the NHS aimed to make primary, urgent, and emergency 
services paperless by 2018--and all other NHS services paperless by 2020--the general 
consensus appears to be that these targets are still years away (Thorlby, n.d.).  
Analogous to the struggle of implementing an effective EHR and making all NHS 
services paperless is the United Kingdom’s shortcoming in failing to maintain a sufficient 
longitudinal record of health data. This information deficiency--particularly within the 
OECD iLibrary Data Warehouse--is what makes the UK one of five countries within the 
analysis that produces no efficiency scores for any of the eighteen separate time periods. 
For this reason and others previously outlined, future plans for the establishment of an 
interoperable EHR system in the UK appear rather bleak. However, the NHS App and its 
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success in offering patients useful electronic resources is yet another testament to the 
advantages of different forms of health information technology and exchange. 
Case Study 5: United States 
For the longest time, the United States healthcare system has been one of the most 
well-known and frequently discussed care networks in the world--for all of the wrong 
reasons. Healthcare coverage in the United States has lived in infamy for decades for its 
hyper-privatization, severe disparities in health delivery, and abysmal rates of uninsured 
individuals. Even more abhorrent than these disappointing attributes is the grim reality 
that the country has continually maintained exceptionally high healthcare costs without 
experiencing comparable gains in population health. One might even consider this the 
legacy of the United States healthcare system: spend more and get less in return.  
With the emergence of the internet and web-based software at the turn of the 
century, many within the government believed technological innovation could pose a 
potential solution to some of the dilemmas plaguing the healthcare system. During 
President George W. Bush’s time in the Oval Office, the budget for healthcare IT projects 
doubled and a new sub-cabinet position of National Health Information Coordinator was 
created (University of Scranton, n.d.). At the start of President Barack Obama’s tenure in 
the White House, an even more progressive move towards the adoption of healthcare 
technology was proposed with the American Recovery and Reinvestment Act (ARRA) 
and its subtitle, the Health Information Technology for Economic and Clinical Health 
(HITECH) Act. Signed into law in February of 2009, both of these laws were enacted to 
“promote the adoption and meaningful use of health information technology...and address 
the privacy and security concerns associated with the electronic transmission of health 
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information,” (U.S. Department of Health and Human Services, 2017). A portion of this 
legislation was dedicated to strengthening the criminal enforcement of HIPAA (Health 
Insurance Portability and Accountability Act) passed by Congress in 1996, but the 
HITECH Act was equally dedicated to constructing an electronic health record system 
and encouraging industry-wide adoption within the decade. Both the ARRA and 
HITECH Act led to significant investments in HIE--more than $30 billion--and 
established financial incentives for physicians and hospitals to adopt EHR systems under 
what is now known as the EHR Incentive Program (The Commonwealth Fund, n.d.).   
A well-established and high-functioning electronic health record in the United 
States was hypothesized to lead to a number of improvements in the healthcare system--
not only from the perspective of cost, but also of quality of care delivered to each and 
every patient. The ability to access and update medical information remotely made an 
electronic method of keeping records very appealing and ultimately justified both 
physicians’ decisions to invest in EHRs to improve their practice and the government’s 
decision to subsidize some of these implementation costs. Unique to other countries 
examined, the United States went a step further to ensure that professionals choosing to 
adopt these systems implemented them in an effective and economical manner. Thus, the 
concept of “Meaningful Use” was established under the EHR Incentive Program with 
three different Meaningful Use stages: Meaningful Use Stage 1, Meaningful Use Stage 2, 
and Meaningful Use Stage 3.  
The first of these stages includes meeting 14 to 15 out of 20 core requirements 
and 5 out of 10 menu requirements such as the ability to record demographics, use 
computerized order entry (COE) for medication orders, send reminders to patients for 
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preventative/follow-up care, and implement simple clinical decision support (CDS) 
suggestions (HealthIT, 2012). The second stage of Meaningful Use expanded upon Stage 
1 to encourage improved functionality of EHR systems--that is, meeting more than 15 
core requirements and more than 5 menu requirements. In October 2015, the Centers for 
Medicare and Medicaid Services (CMS) released requirements for achieving Stage 3 of 
Meaningful Use, which focused on EHR systems improving health outcomes and care 
delivery by 2018 (CDC, 2019). While researchers have yet to receive results on this data, 
it is clear that EHR adoption in the United States has drastically increased since the 
beginning of its implementation. As of 2015, 84% of physicians use some form of EHR 
system and three out of four hospitals (76%) have adopted some basic form of EHR 
system. This represents an eightfold increase in EHR implementation since 2008 (The 
Commonwealth Fund, n.d.). The ARRA, HITECH Act, and EHR Incentive Program 
were all designed to gradually raise the threshold for EHR implementation and 
functionality across the United States. Up to this point, these initiatives seem to be 
achieving their goal in that regard. 
The differences between continued improvement in the United States; partial 
success in Canada; and ranges of ineffective implementation in countries like Japan and 
the United Kingdom depend on variables such as history of EHR use; current level of 
implementation; outlook for the future; and much more. While Canada has saved 
hundreds of millions with initial EHR systems, their implementation rates among 
physicians and hospitals remain considerably lower than those in the US. More 
importantly, where countries like Japan and the United Kingdom appear rather content in 
maintaining the health information systems they currently have in place, the United 
Pfaehler 80 
States is continuously demanding more from EHR systems and improving the 
functionality of the technology as a result. Woefully, our analysis is unable to corroborate 
this assessment due to missing efficiency scores of the United States’ healthcare system 
from 2011 to 2017. Therefore, whether or not the US has succeeded in increasing the 
quality of care, health outcomes, and efficiency of their healthcare system through the use 
of EHR and HIE remains to be determined.  
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Chapter Seven: Conclusion 
 Ephemeralization is a term intimately linked with the concept of efficiency and it 
is especially relevant in the context of our increasingly modernizing world. This term, 
coined by R. Buckminster Fuller, refers to the ability of technological advancement to do 
“more and more with less and less until eventually you can do everything with nothing,” 
(Fuller, 1938). Fuller’s vision was that ephemeralization could continue to rectify ever-
increasing standards of living with an ever-growing population despite a finite supply of 
resources. This subsidiary of efficiency may seem like nothing but a pipe dream. After 
all, basic concepts as elementary as the laws of conservation of energy and mass state 
very clearly that something cannot be created out of nothing. However, attaining higher 
levels of efficiency within our daily lives and governmental systems is absolutely 
imperative as populations continue to grow and societies continue to develop. 
 As with any large transformative process, some sectors of life and government 
have already begun to take the leap of increasing their efficiency by adopting 
increasingly dynamic methods of production. Food systems have developed farming and 
agricultural methods that grow produce and livestock bigger and faster and transportation 
systems have evolved to move more people over longer distances in shorter amounts of 
time than ever before. Healthcare systems have likewise adapted to changes in population 
and technology growth. Innovations such as artificial intelligence, virtual reality 
simulations, and three-dimensional printers are just a handful of a seemingly endless 
number of cutting-edge technologies that have helped healthcare professionals today 
improve their quality of care and do more with less--but can innovations like these alone 
slow the tide of much greater problems soon to be brought about by the epidemiological 
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shift of our modern era? This transition from treating patients with one-time, acute 
illnesses to dealing with older, more obese, and increasingly immunocompromised 
victims of chronic disease has already placed a heightened strain on healthcare systems 
around the world that will only intensify as time passes. It is precisely for this reason that 
new technological advancements in healthcare delivery should be both broadly explored 
and meticulously assessed. 
One innovation in particular--the electronic health record (EHR)--shows 
promising signs of the ability to improve healthcare delivery and thus increase entire 
health system efficiency. Electronic health records are defined as ‘a longitudinal 
electronic record of patient health information generated by one or more encounters in 
any care delivery setting. Included in this information are patient demographics, progress 
notes, problems, medications, vital signs, past medical history, immunizations, laboratory 
data, and radiology reports,’ (Menachemi, 2011, p. 48). The three functionalities that 
make EHRs so attractive as a potential solution to health system inefficiency and rising 
healthcare costs are clinical decision support (CDS) tools, computerized physician order 
entry (CPOE) systems, and health information exchange (HIE) capabilities (Menachemi, 
2011). Yet, despite these dynamic functions, EHRs are also frequently critiqued by those 
skeptical of their practicality and efficacy in healthcare settings because they can be 
expensive, difficult to implement effectively, and even lead to burnout among healthcare 
workers (Brown, 2019). This contrasting sentiment about the influential nature of EHRs 
begs the question whether this recently implemented medical technology has affected the 
health system efficiency of countries choosing to implement this tool--and if so, to what 
end and extent?    
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 In order to answer this research question, the idea of efficiency was first defined 
in a number of ways. It proved important to identify both a general definition of 
efficiency--to produce desired results with little or no waste of time or materials--and 
apply this definition more broadly in order to understand the concept of healthcare 
efficiency--the extent to which inputs to the health system are used effectively to secure 
valued health system goals. After accomplishing this task, this knowledge was used in 
coordination with the different terms of allocative and technical efficiency to provide a 
naive framework for thinking about healthcare system efficiency. This framework was 
then enhanced by explaining the different inputs and outputs under consideration within a 
health system as well as highlighting several environmental variables like governmental 
constraints, population aging, etc. which help control for potential confounding variables 
within any efficiency study. Such a comprehensive framework not only provided an 
exemplary foundation for future efficiency studies, but also took into account studies of 
efficiency at the international level. Thankfully, this model mitigated many of the 
difficulties surrounding the nuance of a fifteen country healthcare efficiency analysis. 
Where other blueprints struggle to compensate for the number of differences in 
healthcare and governmental policies, the aforementioned framework effectively 
compared any and every country so long as they were determined to be reasonably alike. 
Having established this comprehensive framework for modeling international 
healthcare system efficiency, all that remained of the study was to decide upon each of 
the fifteen countries under consideration, select the appropriate analytical method for 
determining healthcare efficiency scores for each country, and effectively calculate and 
interpret the analysis’ results. The first of these undertakings was rather easy to complete 
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as each of the fifteen countries chosen is comparatively modernized and industrialized 
with a health system that is unique, diverse, and rather high functioning. Even more 
important was the fact that each of these countries holds membership in the OECD and 
continuously updates database profiles which contain countless insights into the 
operational capacity of their respective healthcare systems.  
Unfortunately, there are countless reasons why completing healthcare efficiency 
analyses proves so burdensome. One of the main reasons for this difficulty is the lack of 
consensus on which analytical method to utilize to perform such an analysis. Two of the 
more favorable methods that have grown in popularity over the last several decades are 
known as Data Envelopment Analysis (DEA) and Stochastic Frontier Analysis (SFA). 
Over 400 published applications have used these methods within health care settings over 
the past 30 years (Cylus, 2016, p. 99). Both methods see efficiency as a simple 
relationship between inputs consumed and outputs produced and assess how effectively a 
unit of production, such as a hospital, uses its own inputs, such as staff and drugs, to 
produce outputs, such as patients treated. However, where DEA often focuses on 
complicated linear programming methods that place weights on certain inputs and 
outputs, SFA uses statistical regression methods that combine all variables into a single 
aggregate measure. SFA measures relationships between variables in ways that are 
frequently regarded as more user-friendly and easily understandable. This fact--compiled 
with the reality that online resources and research professionals were more easily 
available to assist in a study using a SFA approach--made the decision to utilize SFA a 
rather easy decision. 
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Even with the help of online resources and research professionals, completing the 
Stochastic Frontier Analysis was assuredly the most difficult portion of the entire 
research project. An immense amount of time was consumed to identify reliable 
databases, create and organize datasets, and locate individuals to assist in completing the 
analysis. The largest of these delays occurred due to a lack of information and resources 
available both online and through the university. While there were several individuals 
who provided assistance in other areas of the project, few had the expertise to contribute 
to a DEA or SFA analysis pertaining to the healthcare sector. In the future, my personal 
recommendation for students is to either consider using simpler regression methods in 
STATA from the onset of their project or plan on hiring third-party research experts on 
platforms such as Upwork for assistance in completing more complex analytical 
approaches. Although, even this action may not yield findings considerably more 
pragmatic than those previously outlined in Chapter Five. 
Ultimately, almost all of these actions--defining efficiency, contextualizing this 
understanding of efficiency within the healthcare sector, highlighting the difficulties of 
international country comparisons, explaining analytical approaches to healthcare 
efficiency analysis, and performing a Stochastic Frontier Analysis--produced little 
conclusive data in determining the impact EHRs and HIE have had on international 
healthcare system efficiency. Fortunately, Table 5.1 and Table 5.2 provide some 
practicable information on the effectiveness of certain input variables to the hospital 
sector--most notably, the positive effect of increasing the number of physicians employed 
in hospitals. Perhaps the most useful findings relating to the current state of EHR and 
HIE use are located within Table 5.5, which provides the initial dates of EHR 
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implementation and an index score for each respective country as well as each EHR 
implementation’s respective names. This data, along with a number of other findings, is 
certainly useful information that could contribute to the advancement of future studies. 
More importantly, it is imperative to emphasize the significance of this study even 
without validating its findings--regardless of how limited they may be. The reality of all 
international healthcare analysis is that researchers are already fighting an uphill battle 
when they make the decision to attempt to study such complex and varying systems. As 
proven by the explanations provided in this research project, performing efficiency 
studies of any degree can be a complicated process, but even more so in the context of 
healthcare--and especially at the international level. More complex methods of analysis 
using statistical programming like DEA only further complicate these matters and make 
arriving at results as well as statistical significance even more difficult to determine. Even 
when data is readily available, such a challenging field of study requires highly 
specialized and knowledgeable professionals to make sense of such information. 
Nevertheless, the truth remains that the nuance surrounding the evaluation of healthcare 
systems and their efficiency does not disappear despite the seemingly insurmountable 
obstacle of arriving at conclusive results. Instead, national and global researchers alike 
should continue to push forward to develop new and improved metrics and measures in 
order to find solutions to these increasingly complex problems. While this analysis may 
fall short in determining the abiding effects of international EHR and HIE 
implementation today, perhaps the information presented can prove helpful in 
determining the outlook of such technology for the future.  
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Admittedly, this data analysis seems to raise more questions about both the long-
term efficacy of EHRs and the feasibility of performing international healthcare 
efficiency analyses than it does affirm optimistic sentiments about health information 
technology as a whole. However, this ambiguous conclusion seems quite poetically just 
for a topic surrounded by such immense debate and uncertainty. With each and every 
passing week, new information is brought forth deeming EHRs the savior of healthcare 
efficiency, the bane of every physician’s existence, and everything in between. Despite 
this extraordinary ambivalence, it is clear that--for one reason or another--EHRs and HIE 
are absolutely here to stay for the foreseeable future. After all, the quest for efficiency is a 
pursuit that has consumed the thoughts of governments around the world for generations; 
and while the concept of ephemeralization might be too utopic for some world leaders to 
bear, the need for healthcare systems to improve their quality of care for patients who 
continue to grow older, more obese, and increasingly afflicted with chronic diseases is an 
obligation that will not disappear anytime soon.  
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Appendix 
Entry 1: STATA Do File Command 
 
*Provided by Upwork Freelancer Deni Mazrekaj* 
 
***STOCHASTIC FRONTIER ANALYSIS*** 
 
clear 
import excel "/Users/davidpfaehler/Desktop/Thesis - Extended Data Sheet 
>  STATA.xlsx", sheet("Efficiency") firstrow 
drop tdum* 
 
**FIRST OUTPUT** 
gen logov1 = log(ov1) 
global y logov1 
global x iv1 iv2 iv3 iv4 
global z ev1 ev2 ev3 ev4 ev5 ev6 ev7 ev8 ev9 ev10 ev11 ev12 
 
*Remove Missing observations* 
/*For a cleaner analysis you can drop the missings, but the problem of convergence will 
occur due to a small sample*/ 
*drop if 
missing(logov1,ov2,iv1,iv2,iv3,iv4,ev1,ev2,ev3,ev4,ev5,ev6,ev7,ev8,ev9,ev10,ev11,ev12
) 
 
*Cross-sectional Stochastic Frontier Analysis* 
sfcross $y $x, distribution(tnormal) 
/*overall efficiency*/ 
predict effcross1, bc 
/*Efficiency by country*/ 
bys country: egen effbycountry1 = mean(effcross1) 
tab effbycountry1 country 
/*Efficiency by country and year*/ 
br country year effcross1 
/*effect of environmental variables: 
Ideally you would do this in a single stage, however problems of converge occur, so it's 
in two stages here*/ 
reg effcross1 $z 
 
*Panel Stochastic Frontier analysis 
/*For a more correct analysis, a panel model should be performed as below,  
however convergence problems occur as the data is not suitable for this analysis*/ 
*xtset country year 
*sfpanel $y $x, distribution(tnormal) 
*predict effpanel1, bc 
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*sum effpanel1 
*reg effpanel1 $z 
 
**SECOND OUTPUT** 
gen logov2 = log(ov2) 
global y logov2 
 
*Cross-sectional Stochastic Frontier Analysis* 
sfcross $y $x, distribution(tnormal) 
/*overall efficiency*/ 
predict effcross2, bc 
/*Efficiency by country*/ 
bys country: egen effbycountry2 = mean(effcross2) 
tab effbycountry2 country 
/*Efficiency by country and year*/ 
br country year effcross2 
/*effect of environmental variables: 
Ideally you would do this in a single stage, however problems of converge occur, so it's 
in two stages here*/ 
reg effcross2 $z 
 
*Panel Stochastic Frontier analysis 
/*For a more correct analysis, a panel model should be performed as below,  
however convergence problems occur as the data is not suitable for this analysis*/ 
*xtset country year 
*sfpanel $y $x, distribution(tnormal) 
*predict effpanel2, bc 
*sum effpanel2 
*reg effpanel2 $z 
 
 
 
